FUNMAN
6年前
WILDFLOWER REPORTS REVENUES OF $5.3 MILLION
https://seekingalpha.com/pr/17888240-wildflower-reports-revenues-of-5_3-million
Tue June 2, 2020 12:08 AM|GlobeNewswire|About: WLDFF
VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (WLDFF) (CSE: SUN, OTC: WLDFF) (the “Company”) announces $5.3M in revenues in its third quarter, compared to $2.5M in the previous year’s third quarter and $5.5M in the second quarter. Revenues were slightly less than last quarter even though business was affected by Covid-19. Even with these unforeseen circumstances Wildflower was able to operate with a net gain of $101,435 compared to a loss of $(1,019,862) Q3 2019.
Highlights for the quarter ending March 31, 2020 (with comparisons to the prior year’s quarter except as otherwise noted) include the following:
Revenues of $5,301,762 (Q3 2019: $2,547,230), including sales in British Columbia’s provincially regulated cannabis market, US nationwide e-commerce sales, nationwide US wholesale sales and from the sales in California’s State’s regulated market through the licenses held there;
Cost of goods sold of $2,616,540 (Q3 2019: $1,494,760) related to the cost of the products and packaging sold during the period;
Wages and benefits of $1,428,157 (Q3 2019: $726,961) related to wages and related benefits paid to employees;
Consulting fees and management fees of $88,477 (Q3 2019: $167,537) related to fees paid to the Company’s CEO, CFO, COO and board of directors, as well as individuals providing business consulting services;
Advertising and marketing costs of $11,910 (Q3 2019: $157,823) related to advertising and marketing campaigns for the Company’s cannabis products;
Investor relations and shareholder communications of $144,435 (Q3 2019: $2,177) related to fees paid to investor relations personnel and costs associated with public relations;
Professional fees of $241,011 (Q3 2019: $42,001) related to general corporate matters;
General office and miscellaneous expenses of $202,186 (Q3 2019: $91,635) related to office supplies and incidental expenditures for the Company’s Vancouver-based offices, Washington State subsidiary office, and Californian subsidiary office;
Interest expense of $620,882 (Q3 2019: $189,676) related to the interest accrued on the loans payable, lease obligations, promissory notes and convertible debentures issued during the period;
Foreign exchange gain (loss) of $1,190,901 (Q3 2019: $(177,284)) related to translating the transactions of the Company’s foreign subsidiaries with a functional currency other than the Canadian dollar.
Covid-19 Update
The Company has been monitoring the COVID-19 outbreak and its impact on its business. The situation is dynamic and the ultimate duration and magnitude of the impact on the economy and our business are not known at this time. These impacts could include an impact on our ability to maintain operations, to obtain debt and equity financing, access to necessary supplies, credit risk associated with our accounts receivable, impairments in the value of our long-lived assets, or potential future decreases in revenue or the profitability of our ongoing operations. The Company continues to work diligently to ensure operations continue while continuing to emphasize the safety of our employees and customers.
Company-wide protocols have been developed to enforce increased hygiene measures such as hand washing, social distancing, and COVID-19 symptom scanning. In the current environment, the Company has prioritized risk-mitigation and business continuity planning for the safety of the team, community and maintenance of on-going operations.
The current COVID-19 situation has created an unprecedented operating environment for many businesses, including Wildflower. Cannabis retail has been deemed an essential service and allowable business in British Columbia and City Cannabis stores remain open with reduced operating hours and a limited number of customers in a store at any given time. Although operations have not been materially disrupted, Wildflower follows a general practice of continually pursuing optimization strategies and is collaborating with landlords and investigating government sponsored assistance programs that would further solidify corporate stability. Trust has always been one of the Company’s core business values and now, in the face of the COVID19 pandemic, trust is prioritized more than ever. Wildflower cares deeply about the safety and well-being of its employees, customers, and partners, and has put measures in place to ensure stores are clean and safe.
The COVID-19 outbreak has also resulted in legislative change to how City Cannabis can sell. The Company is now permitted to have an online ordering system by way of click-and-collect. The Company immediately launched its own click-and-collect platform which allows consumers the convenience of ordering their products online and quickly go into a store and collect their purchase. This allows for fewer and quicker interactions between consumers and staff.
Wildflower’s US operations have been curtailed due to the closure of so many retail locations the Company’s products are sold at. Manufacturing and sales activities have been scaled back to align our resources with the current business environment. The Company is also investigating government sponsored assistance programs to support our employees and their families.
Supply chains have been evaluated for input ingredients and packaging as well as transportation logistics. 3 month supplies have been secured. While we believe we will not have any supply disruptions, our suppliers have all warned things can change quickly and there are no assurances in the current marketplace.
ABOUT CITY CANNABIS CO.
City Cannabis is a premier cannabis retailer recently acquired by Wildflower Brands and holds three of the eight City of Vancouver licenses to sell cannabis and the only company with four licenses in the Province of B.C. City Cannabis has been profitably operating various dispensaries in Vancouver since Vancouver commenced licensing cannabis retailers.
For more information about City Cannabis, visit citycannabis.co.
ABOUT WILDFLOWER BRANDS INC.
Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of our brands work in synergy, toward becoming a global wellness leader.
For more information about Wildflower Brands, visit wildflowerbrands.co. To learn, engage and shop our wellness products visit buywildflower.com.
Investor Relations Contact:
ir@wildflowerbrands.co
1-604-559-0420
Cautionary and Forward-Looking Statements
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Forward-looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.
Wire Service Contact:
NetworkWire (NW)
New York, New York
www.NetworkWire.com
212.418.1217 Office
Editor@NetworkWire.com
FUNMAN
6年前
Private Placement
Press Release | 03/03/2020
Wildflower Brands Inc.
This is actually great news. It's very dilutive, but since it's being used to open two Ontario stores, it's a very accretive move IMO - FUNMAN
VANCOUVER, British Columbia, March 03, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (CSE: SUN) (the “Company”) announces it will complete a private placement of units (“Units”) at a price of C$0.15 per Unit for aggregate gross proceeds of up to $530,000. The financing is fully subscribed and will close this week. Each Unit shall consist of one common share of the Issuer and one share purchase warrant (“Warrant”). Each Warrant will entitle the holder to acquire one common share of the Company at a price of $0.30 for a period of 12 months following the closing date of the private placement.
The proceeds of the financing will be used for working capital and to commence design and permitting work for the Company’s two Ontario stores it currently has under lease.
The securities issued will be subject to a four month hold period. No finder’s fee will be paid on the funds raised.
ABOUT WILDFLOWER BRANDS
Wildflower Brands is a company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts.
On Behalf of the Board of Directors
“William MacLean”
___________________
William MacLean
Director and CEO
Cautionary and Forward-Looking Statements
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Forward-looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.
Wire Service Contact
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
FUNMAN
6年前
Wildflower Reports Revenues of $5.5 Million and an Operating Gain of $262,579
Tue March 3, 2020 12:12 AM
GlobeNewswire
About: WLDFF
VANCOUVER, British Columbia, March 03, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (WLDFF) (CSE: SUN, OTC:WLDFF) (the “Company”) announces more than $5.5M in revenues in its second quarter, compared to $1.4M in the previous year’s second quarter and $6.3M in the first quarter. Revenues were expected to be down due to the Robson store having to close in order to move to its newly renovated, licensed 2,800 square foot facility at Robson and Granville. This was the first cannabis retail license the regulators moved in British Columba.
Further, revenues were expected down due to a steep drop in vape sales due to the vapegate crisis.
Highlights for the quarter ending December 31, 2019 (with comparisons to the prior quarter except as otherwise noted) include the following:
* Revenues of $5,514,502 (Q2 2018: $1,410,135), including sales in British Columbia’s provincially regulated cannabis market, US nationwide e- commerce sales, nationwide US wholesale sales and from the sales in California’s State’s regulated market through the licenses held there;
* Cost of goods sold of $2,705,797 (Q1 2018: $810,698) related to the cost of the products and packaging sold during the period;
* Wages and benefits of $889,613(Q2 2018: $296,889) related to wages and related benefits paid to employees;
* Consulting fees and management fees of $192,543 (Q2 2018: $211,656) related to fees paid to the Company’s CEO, CFO, COO and board of directors, as well as individuals providing business consulting services;
* Advertising and marketing costs of $107,808 (Q2 2018: $8,557) related to advertising and marketing campaigns for the Company’s cannabis products;
* Investor relations and shareholder communications of $115,688 (Q2 2018: $12,824) related to fees paid to investor relations personnel and costs associated with public relations;
* Professional fees of $134,802 (Q2 2018: $27,410) related to general corporate matters;
* General office and miscellaneous expenses of $291,199 (Q2 2018: $73,841) related to office supplies and incidental expenditures for the Company’s Vancouver-based offices, Washington State subsidiary office, and Californian subsidiary office;
* Interest expense of $626,488 (Q2 2018: $184,097) related to the interest accrued on the loans payable, lease obligations, promissory notes and convertible debentures issued during the period;
* Foreign exchange gain (loss) of ($274,597) (Q2 2018: $627,339) related to translating the transactions of the Company’s foreign subsidiaries with a functional currency other than the Canadian dollar.
* Net gain (loss) before other items of $265,579 (Q2 2018: (299,812) related to the business operations.
ABOUT WILDFLOWER BRANDS
The Company is a Vancouver-based pioneer in the cannabis industry that develops, designs and operates brands throughout North America. Our brands work together to make Wildflower a leader in cannabis innovation throughout the globe. The Company operates British Columbia’s largest retail cannabis chain under the brand City Cannabis Co.
On Behalf of the Board of Directors
“William MacLean”
____________________________
William MacLean
Director and CEO
The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.
Wire Service Contact
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
FUNMAN
6年前
Wildflower Brands CEO talks unsustainable business models, challenges, opportunities and more
In this edition of "Rising High," The Fly conducted an exclusive interview with William MacLean, chief executive officer of Wildflower Brands (WLDFF), a Vancouver-based company that develops and designs brands focused on plant-based wellness products. Here are some of the highlights:
https://thefly.com/landingPageNews.php?id=3037030&headline=WLDFF;CGC;ACB;TLRY;SPRWF;APHA;CVSI;CTST;CRON;CANN;IGC;TCNNF;ZYNE-Rising-High-An-exclusive-talk-with-Wildflower-CEO-on-unsustainable-models
UNSUSTAINABLE BUSINESS MODELS: Cannabis stocks have started to decline despite decent outlooks and MacLean said he believes it is due to unsustainable business models. “You had the green rush where investors were throwing money at investments left, right and center and just believing that whatever they did would make money,” he said. This led to initial licensed producers and publicly-traded companies having access to huge amounts of capital with business models based on growing, getting more distribution and getting more product, the CEO said. “They didn’t develop a business model at the end of the day that had a home for the products to go to,” he said. “They were just believing if we grow it, we can sell it and we’d make money.” MacLean said investors began to deploy capital more stringently and through different models. “Ultimately what this created was another wave of investments that were what some investors would call toxic investments, or toxic capital, where there were convertible notes and all these different structures that would put negative pressure on the stock if certain criteria weren’t met or goals reached,” he said. The CEO added companies started acquiring, merging or forming joint ventures with companies with valuations “that were raised through roof” leading to write offs and write downs on assets that would continue to put downward pressure on capital. “Based on the fact that you would have all that downward pressure, capital has now started to dry up and business models were terribly capital dependent, you now see this environment where a lot of these companies are positioned to fail.” He said evidence of this can be seen in the CEO transitions at Canopy Growth (CGC) and Aurora (ACB) as well as workforce reductions at Aurora, Tilray (TLRY) and Supreme (SPRWF). “At the end of the day, if you built your company to be cash dependent, you have not built a sustainable model and you’re going to be in trouble this year,” he said.
BACK TO FUNDAMENTALS: When asked about how he sees the cannabis landscape moving forward, MacLean said there has already been a shift towards companies looking for more sustainable business models and going back to the fundamentals. “These companies are going to start being more focused on their value proposition and more focused on what part of the market or sectors they’re focused on,” he said. “You’re going to see a lot of cutbacks from excess spending and anything outside of what their core competency should be.” The CEO said he believes there will be a clear separation of companies that are progressing versus companies that are in a position to fail. “The problem is that some of these companies that might be positioned to fail might be really big ones that really impact the entire sector,” he said. However, MacLean added that he believes investment opportunities are abundant as family offices emerging as investors in the space. “What family offices tend to do right is they’re never the very first ones to move on an opportunity or a new wave,” he said. “Instead they kind of want to sit back and see how things play out before they invest in that and then when they do invest, they tend to invest a lot longer-term, not the in and out you often see.” The CEO said a pullback in valuations has created a new entry point for family offices and as regulations start to roll out, they have become more open to investing capital.
STEADY GROWTH: MacLean said Wildflower was never capitalized massively to begin with and therefore has grown at a very steady rate. “We haven’t grown super fast and we haven’t had to get a ton of capital in the door to do it,” he said. “We’ve built it based on fundamentals built on creating a profitable business model.” The CEO said the only reason the company is not making a lot of money currently is investment to continue growth. “I think what you’re going to see is a lot of companies, especially ourselves, we’re going to be really focused on the greatest ROI on any investment,” he said. MacLean added that Wildflower also has a huge benefit of access to the consumer through its City Cannabis acquisition. “We have now done almost half a million transactions in the cannabis retail stores that provides immense feedback,” he said. He said he sees the retail part of the sector fueling the company for the next few years, but the wellness space and the CBD side of the company as the long-term component. “We’re really just starting to scratch the surface on the wellness side in CBD and cannabis in general and we see that as a long-term opportunity,” he said. “Combining these two allows us short-term growth and profitability eventually leading into our long-term expansion.”
CHALLENGES: When asked about the biggest challenges facing the company, the CEO said he believes capitalization has always presented a hurdle. “We’ve never had tens and tens of millions of dollars in the bank to go and do whatever we wanted,” he said. “Now we’re having certain funds and investors looking at us because we are one of the few that essentially have a sustainable business model and strong cash flow.” Looking at the market as a whole, MacLean said he sees one of the biggest obstacles in how cannabis firms are lumped together regardless of their success or failure. “You know if Canopy comes out with good earnings, the entire sector will go up,” he said. “We’re not being judged independently on our own companies right now, which is an issue.” The CEO said he sees another challenge from the bad decisions made by the CEOs and executives that have jumped into the industry “but have no business running a cannabis company... They have basically created a such a mess in the industry that now the capital for the investment community is really drying up because there’s a lot of people that have a bad taste from investing in it.”
OPPORTUNITIES: As the cannabis space develops, MacLean said he believes the biggest opportunity in the market is in wellness. “If you look at the rec side globally, what’s the size of the global recreational cannabis market? You know, arguably you could say somewhere in the $50-$100B range, right?” he said. “Then why when you look at the nutraceutical industry it is more than two, three, four times that. I really think the opportunity lies in the wellness side of things, but I think it’s still going to be quite some time before that really plays out.”
FLOWER VS. DERIVATIVES: When asked about how he expects the use of flower and derivatives to shift over time, the CEO said he sees both vaporizers and topicals being huge parts of the industry moving forward. “Obviously with the whole vapegate that happened over the last little while with the illicit vaping products on the market causing harm, that definitely slowed that growth,” he said. “We lost about 80% of our vaporizer business during this whole thing but I would have singled out vaping as one of the major ones.” MacLean said he also expects topicals to be a large portion of the sector because they’re not ingestible. “The barrier to entry into market is a lot lower for topicals so I think that’s going to be one of the largest segments initially, long-term maybe not but initially yes,” he said. “In terms of other delivery systems out there, I think you’re going to see ingestibles play a major part. It’s going to be a part of your regular health maintenance and supplementary regimen.”
OTHER CANNABIS STOCKS: Other publicly-traded companies in the space include Aleafia (ALEAF), Aphria (APHA), Aurora Cannabis (ACB), Biome Grow (BIOIF), CannTrust (CTST), Canopy Growth (CGC), Canopy Rivers (CNPOF), Cresco Labs (CRLBF), Cronos Group (CRON), CV Sciences (CVSI), Delta 9 (VRNDF), DionyMed Brands (DYMEF), Elixinol Global (ELLXF), General Cannabis (CANN), Greenlane (GNLN), GrowGeneration (GRWG), Harborside (HSDEF), Hemp Inc. (HEMP), Hexo (HEXO), India Globalization Capital (IGC), Indiva (NDVAF), ICC International Cannabis (WLDCF), Innovative Industrial Properties (IIPR), Khiron Life Sciences (KHRNF), Liberty Health Sciences (LHSIF), MediPharm Labs (MEDIF), MedMen Enterprises (MMNFF), MJardin (MJARF), Organigram (OGI), Origin House (ORHOF), Planet 13 Holdings (PLNHF), Real Brands (RLBD), Sproutly (SRUTF), Sunniva (SNNVF), Tetra Bio-Pharma (TBPMF), Tilray (TLRY), Trulieve (TCNNF), Vireo Health (VREOF), Wayland Group (MRRCF), WeedMD (WDDMF), Westleaf (WSLFF) and Zynerba (ZYNE).
Symbols: WLDFF CGC ACB TLRY SPRWF APHA CVSI CTST CRON CANN IGC TCNNF ZYNE
Keywords: cannabis, weed, stocks, marijuana, cultivation, legalization, CBD, THC, hemp
FUNMAN
6年前
Made it into Forbes Magazine...The 5 Best CBD Topicals For Pain Relief (Plus 2 Highly-Effective THC Balms)
(Wildflower is listed first. See Blue.)
By: Karla Alindahao Senior Contributor
ForbesLife, I write about travel and food. So I love forks in the road.
https://www.forbes.com/sites/karlaalindahao/2020/01/28/best-cbd-topicals-for-pain-relief-2020/?mc_cid=05cea4e7c7&mc_eid=64022d8443#13a8d22213bf
I am, by no means, “athletic.” But like most New Yorkers, I try. (After all, this is a city of strivers and fitness-obsessed type-A individuals who like to rock Alo Yoga and Outdoor Voices gear.)
But I don’t engage in physical activity solely because of my woefully wobbly midsection. My sanity depends on it. Truly. In the immortal words of Elle Woods: Endorphins make you happy!
In my early thirties I dabbled in SoulCycle, swimming at the 14th Street Y, and three disastrous attempts at SLT. These days it’s running loops in Central Park, Y7 yoga, and contact combat. And let me tell you, hitting a weekly fitness goal isn’t always easy—especially when you’re rapidly approaching your 40s with a few minor injuries under your belt.
I’m no spring chicken and the occasional bout of soreness is now a fact of life.
So recovery is a big deal. And personally, I’m all about CBD (a.k.a cannabidiol)—the non-psychoactive compound in cannabis. It’s been having a moment these past few years, making appearances in all sorts of wellness and beauty products—from CBD edibles, to capsules, to transdermal patches, and beyond. But make no mistake. It’s not the passing health trend that activated charcoal and golden milk used to be.
“CBD is extremely anti-inflammatory and neuroprotective. A normal person may use it to prevent conditions such as arthritis or even topically to prevent acne breakouts,” Dr. Shivani Amin, a physician and cannabis expert who is a member of the AMMPA (American Medical Marijuana Physicians Association), says. “I think CBD shows great promise for the future. It all boils down to educating the public about the correct usage and understanding the plant better.”
I’ve long been a fan of edibles and tinctures, but for those who are skeptical of ingesting it, I’m also a big believer in topicals. From lotions and creams to balms and bath bombs, I have experimented with many different kinds—and I’ve come to rely on them for localized pain and reducing inflammation.
But as with any CBD product, there’s no skeleton key that unlocks relief for everyone—you have to find what works for your body. And you certainly have to experiment with different products, brands, and dosages—it’s the only way for you to see which ones really work.
Just know that topicals, unlike edibles, serve a different purpose: They’re primarily for targeted surface areas to address tension, spasms, and muscle pain because CBD applied to the skin doesn’t reach your bloodstream. Think of it as spot treating problematic areas. For instance, if your lower back is shot, apply your preferred product to that area only.
One thing to note, though: Only buy from established brands from licensed dispensaries—not random bodegas, sketchy websites, so-called health food stores, or even Amazon. Always ask for COAs (Certificates of Analysis) to ensure that the topical actually contains the cannabinoids it claims to have. And have an open mind about using CBD topicals incorporated with THC—because those two cannabinoids combined are more effective when addressing inflammation, which is the primary cause of soreness and pain.
“I have treated many patients with chronic conditions with full spectrum CBD and attained great results,” Dr. Amin says. “I also believe the public needs to understand that CBD works in conjunction with THC. Usually this requires at least 3–5% THC to work for serious forms of pain and more chronic medical conditions. I have patients come in with chronic and severe pain expecting to have their pain alleviated with just CBD. Although CBD works well for pain, in many situations patients with severe pain need to have some THC. [The cannabinoids] work synergistically to help ease severe pain.”
Here’s what I have found most effective over the years.
best cannabis topicals for pain relief 2020_Wildflower CBD Cool Stick
WILDFLOWER CBD COOL STICK (300MG; $60)
Wildflower was my inaugural topical. At the time, I had just started learning Krav Maga—a rather intense Israeli contact combat sport where there are no real rules. (Except to survive.) And my body was sore all the time those first few months. It didn’t help that I’ve got this existing and highly-bothersome back condition. I was also running a few times a week. But Wildflower’s CBD Cool Stick, which conveniently comes packaged as a roll-on, helped me tremendously. The trick is to apply the cooling stick before your workout or any other physically strenuous activity—not after. Why? Because in my experience, sweat reactivates the cooling components of the Wildflower’s formula. A six–mile run is infinitely more pleasant when you feel the the cream working even when you’ve got a ways to go. Also note that the brand also carries a Healing Stick (500mg) for $75. But it’s got arnica and I’m not exactly fond of the odor it emits through my clothes. However, if you do like arnica-scented everything, go for it.
best cannabis topicals for pain relief 2020_Populum Cold Therapy
POPULUM COLD THERAPY HEMP RUB (100MG; $45)
Unlike Wildflower, Populum comes in gel form. Also: It’s artic. Kind of like a more aggressive Vick’s Vaporub—so much so that you will definitely need to wash your hands after application. (The last thing you need is to accidentally rub your eyes with that stuff still on your digits.) But it’s effective—despite its relatively low dose of CBD. And a little goes a long way. Use it for minor aches and inconveniences—like when you find yourself stiff because you’ve been sitting on your far-from-ergonomic work chair most of the day. And if you find yourself really hurting, I recommend using a topical that contains both THC and CBD. (More on that below.)
best cbd topicals for pain relief 2020_Lord Jones x Tamara Mellon Stilleto Cream
LORD JONES + TAMARA MELLON HIGH-CBD FORMULA STILETTO CREAM (200MG; $70)
This is every woman’s dream come true. High heels are just not made the way they used to be—stilettos these days are narrower, higher, and pointier. Remember: Louboutin does not concern himself with the comfort of his designs. (He said so himself in the documentary and several other news outlets.) Gone are the days of the sensible heels our grandmothers wore. But alas, sky–high footwear is a necessary evil. So Lord Jones, the wildly–popular CBD company, collaborated with Tamara Mellon to help ease that discomfort. Just dab a little solution onto your feet and wait for your skin to absorb the formula before putting on your four–inch torture device.
BASKIN BODY WELLNESS CBD CREAM (400MG; $60)
Best CBD Topicals_BASKIN Body Wellness Cream
Baskin has a lower–dose formula that clocks in at 150mg CBD that costs $20 less. But I say, Go big or go home. Invest in the higher dose if you want real relief all over: It’s meant to be used all over the body versus its cousin, which was specifically created for smaller targeted areas. Beyond that, you can always use the 400mg cream the way you see fit: Nobody is going to stop you if you want to use it only in specific pain points.
best cannabis topicals for pain relief 2020_Onyx and Rose Bliss Balm
ONYX + ROSE BROAD SPECTRUM CBD BLISS BALM (500MG; $54)
This high–dose balm seems to be a crowd favorite, certainly in my household. The jar itself contains two ounces of product. It doesn’t seem like much—But because the consistency of the cream is particularly smooth and spreadable, it glides easily onto the skin and covers more real estate. In terms of relief, you can expect gradual relaxation of the muscles—especially if you’re prone to spasms or simply incredibly tight.
best cannabis topicals for pain relief 2020_Baskin Glow
BASKIN GLOW (50MG THC + 500MG CBD; $80)
Now this is where we change course. Serious athletes and people suffering from chronic pain will benefit from this lotion. And yes, it’s in a jar but it rubs on like an incredibly light lotion—not at all like a heavy body butter. The main difference is that it contains both THC (tetrahydrocannabinol) in addition to CBD. And that’s a good thing. Both cannabinoids work synergistically together: THC will open up your receptors, enabling your body to absorb and metabolize more CBD. Beyond that, Glow is applied somewhat differently than the rest of the products on this list. Apply a minuscule amount to your pulse points, the insides of your elbows, and the backs of your knees—areas where the skin is at its thinnest. The reasoning: Because of its formula and consistency, your body will absorb the product so that it reaches your bloodstream—unlike many other topicals.
best cannabis topicals for pain relief 2020_Dixie Synergy Relief CBD and THC Balm
DIXIE SYNERGY RELIEF CBD AND THC BALM (50MG CBD + 50MG THC; $45)
I’m a huge fan of Dixie’s edibles, particularly its Birthday Cake White Chocolate and root beer elixir. But the cannabis company also does a damn fine job with its Synergy CBD and THC combo balm. It’s what I reach for whenever I’m too achy and cannabidiol alone just won’t cut it. It all boils down to the fact that the presence of THC opens up receptors in our bodies to allow for greater CBD absorption.
FUNMAN
6年前
William MacLean of Wildflower Brands: “There is a place for big pharma; however, people need ways to proactively support wellness with traditional and plant-based remedies that are affordable and accessible”
By: Alexandra Spirer
Follow
Jan 30
https://medium.com/authority-magazine/meet-william-maclean-of-wildflower-brands-inc-6cb56f4a9763
I would like to inspire the continued movement towards natural ways of supporting health and wellness. There is a place for big pharma; however, people need ways to proactively support and maintain wellness with traditional and plant-based remedies that are affordable and accessible.
I had the pleasure of interviewing, William MacLean. William is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the company to its current success. He continues to build the company with great talent to ensure the company can scale and succeed by all measures. Prior to Wildflower, William was a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank. William studied Political Science at Simon Fraser University.
Can you share with us the story about what brought you to this specific career path?
Sales and marketing have been dominant throughout my career. Before starting Wildflower, my last role was in medical sales and there I saw a global trend towards natural wellness products growing. At the same time, I saw an enormous opportunity in the legalized cannabis space. There were significant new markets and opportunities appearing but there were no recognizable reputable brands that stood out in the marketplace.
Can you share the most interesting story that happened to you since you began leading your company? Can you tell us what lesson you learned from that?
With one of our initial retail stores, the landlord decided to lease the store next door to a competitor to ours. This competitor started offering below-market pricing on some products. Instead of immediately jumping in and competing on price, we decided to go the other way. We decided to focus on providing a great experience and ensuring we were only selling high-quality products. This has translated into a way of operating all our brands and has led to success. There is a market at the lower end, but that is not where we want to be. We always strive to provide fantastic customer experiences and reputable high- quality products at a reasonable cost.
Are you working on any exciting projects now? How do you think that will help people?
The most exciting project is our continued expansion of our retail model. Our retail model has a focus on optimizing the retail experience for our customers who have varied levels of experience. We continually refine our model and especially for the newer demographic of the consumer coming in we create a safe and welcoming space where they can learn all about the products. We help people by informing them through our tools and employees with an industry leading experience. We see competitors beginning to copy our model, and they say imitation is the sincerest form of flattery.
None of us are able to achieve success without some help along the way. Is there a particular person who you are grateful towards who helped get you to where you are? Can you share a story?
I’m particularly grateful for my business partner and friend Stephen Pearce. My second meeting with Stephen was where we visited a potential production facility together. On this trip, Stephen brought his son Noah with him and I saw more than his business side. It was there that we founded our business relationship on a handshake. Stephen background as a lawyer paired with his capital markets experience has been invaluable for us to get to where we are. We really play off each other’s strengths and are a formidable team.
This industry is young dynamic and creative. Do you use any clever and innovative marketing strategies that you think large legacy companies should consider adopting?
There are tons of agencies that will pitch boilerplate services and work. We always see these come in at a high cost without much in terms of meaningful KPIs that help build our business. Whereas many people immediately go to influencers and a heavy social media presence, we buck the trend and have focused on ensuring we have a high quality and effective product. We treat every customer service experience as a marketing opportunity to build our brand, so we guarantee satisfaction with our products. This has helped us grow our company organically with very loyal customers when they know that we will always treat them right. This is something large legacy companies should really consider, ensuring that your focus isn’t just on campaigns and what everyone else does to create just exposure to your brand but to really focus on providing phenomenal experiences across touch points. That builds word of mouth and loyalty that otherwise you would not be able to pay for.
Can you share 3 things that most excite you about the Cannabis industry? Can you share 3 things that most concern you?
How do they relate to the extinction event?
Firstly, even though we have been around for five years, the industry as a whole is in its infancy. With full legalization of cannabis in only a handful of countries, there is lot of exciting potential for companies with a good business. Another exciting thing is how cannabis will fit into the already huge industry of wellness products. Finally, the evolving space of retail for cannabis presents both exciting challenges and opportunities for those who are willing to work with and be adaptable to the restrictive and ever- changing regulatory landscape.
One of my biggest concerns right now is how as a public company we are trading on industry trends instead of our fundamentals. Compared with public companies in other industries, it would be unheard of for a company like ours to have such an undervalued market cap. I have confidence that things will change as people recognize us for who we are and what we have built and not just lump us in with the overall drag of the cannabis industry.
The other concern is somewhat related and this is how some of the biggest cannabis companies have capital intensive business models. These large cannabis companies have significant run rates that can only be sustained with more capital. As the markets have turned less favorable towards cannabis investments many of these players are entering into bad capital situations or acquisitions and mergers of desperation. This is a downward spiral further causing capital markets to dry up for cannabis investments. This relates to extinction event because companies will begin to fold from lack of ability to raise capital.
What advice would you give to other CEOs or founders to help their employees to thrive? To stay safe from the extinction event?
Don’t overextend yourself or the company and focus on creating sustainable business models. A lot of CEOs focus on the customer, but you need to care for employees and customers alike with high regard. It is essential to not enter into funding models that can put the company at risk. Be wary of those who come to you with capital at the cost of odd structures or anything non-traditional that is difficult to understand. These odd funding models can place downward pressure on your valuation making it difficult or expensive to further raise capital or could force debt conversion into stock in a way where you lose control of the company.
You are a person of great influence. If you could inspire a movement that would bring the most amount of good to the most amount of people, what would that be? You never know what your idea can trigger.
I would like to inspire the continued movement towards natural ways of supporting health and wellness. There is a place for big pharma; however, people need ways to proactively support and maintain wellness with traditional and plant-based remedies that are affordable and accessible.
What is the best way our readers can follow you on social media?
I have not been too active on social media, but follow me on LinkedIn. That is where I will share relevant thought leadership and updates that will be interesting to your readers.
FUNMAN
6年前
Is Wildflower Brands (CSE:SUN) A Risky Investment?
Simply Wall St
January 31, 2020
Warren Buffett famously said, ‘Volatility is far from synonymous with risk.’ So it seems the smart money knows that debt – which is usually involved in bankruptcies – is a very important factor, when you assess how risky a company is. We note that Wildflower Brands Inc. (CSE:SUN) does have debt on its balance sheet. But the real question is whether this debt is making the company risky.
What Risk Does Debt Bring?
Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. Part and parcel of capitalism is the process of ‘creative destruction’ where failed businesses are mercilessly liquidated by their bankers. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. When we examine debt levels, we first consider both cash and debt levels, together.
How Much Debt Does Wildflower Brands Carry?
The image below, which you can click on for greater detail, shows that Wildflower Brands had debt of CA$6.46m at the end of September 2019, a reduction from CA$8.73m over a year. However, because it has a cash reserve of CA$968.4k, its net debt is less, at about CA$5.49m.
How Strong Is Wildflower Brands’s Balance Sheet?
We can see from the most recent balance sheet that Wildflower Brands had liabilities of CA$7.61m falling due within a year, and liabilities of CA$12.5m due beyond that. Offsetting these obligations, it had cash of CA$968.4k as well as receivables valued at CA$414.2k due within 12 months. So it has liabilities totalling CA$18.7m more than its cash and near-term receivables, combined.
This deficit isn’t so bad because Wildflower Brands is worth CA$32.9m, and thus could probably raise enough capital to shore up its balance sheet, if the need arose. But it’s clear that we should definitely closely examine whether it can manage its debt without dilution. The balance sheet is clearly the area to focus on when you are analysing debt. But you can’t view debt in total isolation; since Wildflower Brands will need earnings to service that debt. So when considering debt, it’s definitely worth looking at the earnings trend. Click here for an interactive snapshot.
Over 12 months, Wildflower Brands reported revenue of CA$12m, which is a gain of 439%, although it did not report any earnings before interest and tax. When it comes to revenue growth, that’s like nailing the game winning 3-pointer!
Caveat Emptor
While we can certainly savour Wildflower Brands’s tasty revenue growth, its negative earnings before interest and tax (EBIT) leaves a bitter aftertaste. Its EBIT loss was a whopping CA$5.2m. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. So we think its balance sheet is a little strained, though not beyond repair. Another cause for caution is that is bled CA$3.5m in negative free cash flow over the last twelve months. So in short it’s a really risky stock. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet.
FUNMAN
6年前
3 Canadian Cannabis Stocks Leading The Retail Charge In 2020 (see blue)
EDITORIAL
Jan 6, 2020
7:49 AM EST
Although the legalization of recreational cannabis in Canada represented an unprecedented growth opportunity, the industry has faced significant headwinds following a less-than-smooth rollout.
From the number of legal dispensaries to the types of products that can be sold to consumers, a number of factors have contributed to the slow rollout of Canada’s recreational cannabis market and this has put pressure on companies that are levered to this burgeoning opportunity.
We expect 2020 to be a banner year for the Canadian adult use market due to the increasing number of dispensaries and the legalization of cannabis derivative products (i.e. vape pens, cannabis infused products, cannabis concentrates, topicals, and more). We are bullish on the growth prospects associated with Canada’s recreational cannabis market and have highlighted 3 companies that are levered to this vertical of the industry.
Fire & Flower: A Canadian Cannabis Retail Execution Story
Fire & Flower Holdings Corp. (FAF.TO) (FFLWF) has been highly focused on the retail side of the Canadian cannabis industry and this is an opportunity that caught our attention in 2019. During the last year, the company has significantly expanded its reach across Canada, and we are bullish on the growth prospects associated with its footprint.
A few weeks ago, Fire & Flower reported a major milestone and announced that it has started to sell cannabis 2.0 products in its retail stores in Saskatchewan. Cannabis 2.0 refers to the new types of cannabis products that can be sold to recreational consumers and we are bullish on the upside associated with this opportunity.
When looking at the types of products that can be sold to consumers from Fire & Flower retail stores, there is a lot to be excited about. These products include gummies, mints and chocolates; and concentrate vaporizers in both all-in-one and cartridge formats. Fire & Flower works with a majority of the leading Canadian cannabis producers and we expect these relationships to support demand on the consumer level.
During the last quarter, Fire & Flower has been under considerable pressure and we continue to follow this trend. We are impressed by the way the management team has been able to execute and expect the opening of new stores to be a catalyst for the business. Last month, the company reported more than $13 million of quarterly revenue and this is an opportunity that we will continue to monitor.
Canopy Growth: Growing Through Acquisitions
Through a series of acquisitions, Canopy Growth Corporation (WEED.TO) (CGC) has become highly levered to the Canadian cannabis retail market and this is an opportunity that we continue to closely follow. A few years ago, the Canadian cannabis producer reported a major acquisition of Hiku Brands and we continue to monitor how this asset will benefit the entire business.
Although we believe that Canopy Growth paid a huge premium for an unproven retail operator, we are bullish on the long-term growth prospects associated with the cannabis retail market in Canada and will keep an eye on how the company advances this aspect of the story. The last year has been a tough year for the business and we expect 2020 to be a period of substantial growth for the operation.
Canopy Growth recently announced the appointment of a new CEO and this removed a major headwind from this business. During the last quarter, the Canadian cannabis producer has been under considerable pressure and the shares have fallen more than 50% from its all-time highs. We believe that Canopy Growth has substantial potential catalysts for growth and will continue to monitor how the retail side of the business supports growth on a going forward basis.
*As of this morning Tokyo Smoke announced plans to open 10 retail outlets in Ontario in early 2020.
Wildflower Brands: A Vancouver Cannabis Retail Opportunity
When it comes to the Canadian retail market, Wildflower Brands Inc. (SUN.CN) (WLDFF) is an opportunity that is flying under the radar. Last month, the company reported to have generated more than $6 million of revenue in the first quarter and this represents massive growth when compared to the same period last year.
Last year, Wildflower completed the acquisition of City Cannabis Co., a cannabis retailer holding two of the three City of Vancouver licenses to sell cannabis and the only company with multiple licenses in British Columbia. This asset has proven to be the greatest growth driver for the business, and we are favorable on the opportunity for City Cannabis in 2020 and beyond.
One of the reasons we are favorable on this opportunity is due to where the cannabis dispensaries are located. City Cannabis has been profitably operating various dispensaries in Vancouver since the city started licensing cannabis retailers. City Cannabis has multiple cannabis retail license applications that have been submitted in British Columbia and Ontario.
2019 was a tough year for the cannabis sector and Wildflower was impacted by the decline. Although the fundamental story has significantly improved, the recent trend has been to the downside and this is an opportunity that we will continue to follow. Going forward, we expect the opening of new dispensaries to be the biggest catalyst for the story and expect to see several new locations opened this year.
FUNMAN
6年前
Wildflower Reports Record Quarterly Revenues of $6.3 Million
December 21, 2019
https://cannabis-investment-group.com/2019/12/21/wildflower-reports-record-quarterly-revenues-of-6-3-million/
VANCOUVER, British Columbia, Dec. 20, 2019 (GLOBE NEWSWIRE) — via NetworkWire: Wildflower Brands Inc. (CSE: SUN, OTC:WLDFF) (the “Company”) announces more than $6.3M in revenues in its first quarter, compared to $1.0M in the previous year’s first quarter. Revenues from all sources are up, and the largest contributor of the record-breaking revenues was City Cannabis Corp., which was acquired by the Company in June 2019. The revenues for the Company’s first quarter ended September 30, 2019, almost total revenues for the entire year ended June 30, 2019 ($7.1M).
Highlights for the quarter ending September 30, 2019 (with comparisons to the prior quarter except as otherwise noted) include the following:
* Revenues of $6,359,092 (Q1 2018: $1,002,279), including sales in British Columbia’s provincially regulated cannabis market, US nationwide e-commerce sales, nationwide US wholesale sales and from the sales in California’s State’s regulated market through the licenses held there;
* Cost of goods sold of $3,513,818 (Q1 2018: $467,019) related to the cost of the products and packaging sold during the period;
* Share-based payment expense of $2,875,025 (Q1 2018: $106,953) related to the fair value of incentive stock options granted during the period;
* Wages and benefits of $795,736 (Q1 2018: $253,174) related to wages and related benefits paid to employees;
* Consulting fees and management fees of $773,771 (Q1 2018: $158,702) related to fees paid to the Company’s CEO, CFO, COO and board of directors, as well as individuals providing business consulting services;
* Advertising and marketing costs of $130,407 (Q1 2018: $362,884) related to advertising and marketing campaigns for the Company’s cannabis products;
* Investor relations and shareholder communications of $104,551 (Q1 2018: $362,912) related to fees paid to investor relations personnel and costs associated with public relations;
* Legal fees of $236,830 (Q1 2018: $17,966) related to general corporate matters and acquisitions, including the acquisition of City Cannabis Corp.;
* General office and miscellaneous expenses of $232,090 (Q1 2018: $57,723) related to office supplies and incidental expenditures for the Company’s Vancouver-based offices, Washington State subsidiary office, and Californian subsidiary office;
* Interest expense of $624,491 (Q1 2018: $175,135) related to the interest accrued on the loans payable, lease obligations, promissory notes and convertible debentures issued during the period;
* Exchange difference of $508,572 (Q1 2018: $212,983) related to translating the transactions of the Company’s foreign subsidiaries with a functional currency other than the Canadian dollar.
ABOUT WILDFLOWER BRANDS
The Company is a Vancouver-based pioneer in the cannabis industry that develops, designs and operates brands throughout North America. Our brands work together to make Wildflower a leader in cannabis innovation throughout the globe. The Company operates British Columbia’s largest retail cannabis chain under the brand City Cannabis Co.
FUNMAN
6年前
Wildflower Reports 400% Revenue Increase
December 19, 2019
VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) — via NetworkWire: Wildflower Brands Inc. (CSE: SUN, OTC:WLDFF) (the “Company”) is pleased to announce revenue for the fiscal year ending June 30, 2019 of $7.1M – a 400% increase over revenues of $1.4M in 2018. The Company began aggressively marketing its CBD Wellness products during the fiscal year, culminating with the launch of its products in June 2019 at Dillard’s, an American department retail chain with over 290 stores in 29 states.
Highlights for the year ending June 30, 2019 (with comparisons to the prior year except as otherwise noted) include the following:
* Sales of $7,085,223 (2018: $1,408,114), including licensing fees from sales through our partner in the Washington State I-502 market, US nationwide e-commerce sales, nationwide US wholesale sales and from the sales in California State’s regulated market through the licenses held there;
* Cost of goods sold of $3,927,086 (2018: $915,997) related to the cost of the products and packaging sold during the year;
* Wages and benefits of $1,515,177 (2018: $175,669) related to wages and related benefits paid to employees;
* Consulting fees and management fees of $978,018 (2018: $473,735) related to fees paid to the Company’s CEO, CFO, COO and board of directors, as well as individuals providing business consulting services;
* Advertising and marketing costs of $384,616 (2018: $313,068) related to advertising and marketing campaigns for the Company’s cannabis products, as well as funds expended toward the branding of the retail locations in Manhattan under its Retail Worx agreement;
* Investor relations and shareholder communications of $691,532 (2018: $393,420) related to fees paid to investor relations personnel and costs associated with public relations;
* Legal fees of $626,213 (2018: $59,015) related to general corporate matters and acquisitions, including the acquisition of City Cannabis Corp.;
* Bad debt expense of $1,198,808 (2018: $Nil) to recognize an allowance for doubtful accounts related to trade receivables;
* General office and miscellaneous expenses of $430,393 (2018: $166,621) related to office supplies and incidental expenditures for the Company’s Vancouver-based office, Washington State subsidiary office, and Californian subsidiary office;
* Share-based payment expense of $331,222 (2018: $1,924,750) related to the fair value of incentive stock options granted during the year;
* Rent of $331,269 (2018: $101,191) related to office space in Vancouver and Washington State;
* Travel and accommodation of $182,336 (2018: $117,342) related to travel for business activities;
* Write off of loan receivable of $179,867 (2018: $173,236) as the Company deemed the amounts to be unrecoverable;
* Interest expense of $901,406 (2018: $129,770) related to the interest accrued on the loans payable, promissory notes and convertible debentures issued during the period;
* Gain on agreement revision of $810,262 (2018: $Nil) representing the difference in book value of the property and equipment deemed to have been disposed of under an industrial lease agreement and the present value of the lease obligations for the same property; and
* Exchange difference of $321,616 (2018: $454,657) related to translating the transactions of the Company’s foreign subsidiaries with a functional currency other than the Canadian dollar.
ABOUT WILDFLOWER BRANDS
The Company is a Vancouver-based pioneer in the cannabis industry that develops, designs and operates brands throughout North America. Our brands work together to make Wildflower a leader in cannabis innovation throughout the globe. The Company operates British Columbia’s largest retail cannabis chain under the brand City Cannabis Co.
NetworkNewsWire
7年前
Solid Profits Show Strength of Growing Cannabis Space
CannabisNewsWire Editorial Coverage: The cannabis markets have already produced some amazing financial results, but all indications are the industry is only at the beginning of an impressive ascent.
Quarter-over-quarter sales growth is one of the indicators used to indicate upside potential. With that in mind, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) more than tripled its revenues from one year ago, both on a year-over-year and quarter-over-quarter basis, and Scotts Miracle-Gro Company (NYSE: SMG) announced company-wide sales increased 17% in its fiscal second quarter. Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF) grew its first-quarter 2019 revenues by 192% year-over-year to $44.5 million while Acreage Holdings Inc.’s (CSE: ACRG) (OTCQX: ACRGF) first-quarter 2019 performance showed revenues up 487% to $12.9 million.
- Cannabis run is far from over, new winners emerging
- Branding, marketing and retail reach signals of success
- Year-over-year and sequential growth helps identify future potential
To view an infographic of this editorial, click here.
Good Times Have Just Begun
Legal cannabis is a recent worldwide phenomenon, and the emerging market seems to have almost unlimited potential. The global legal marijuana market, valued at just $9.3 billion in 2016, is expected to blow past $146 billion within the next six years.
According to a United Nations report, cannabis is the most widely consumed drug on the planet, with approximately 270 million global consumers using cannabis, equivalent to about 4% of the world’s population, barely a dent in market penetration. As marijuana makes its way into the mainstream, usage among all age groups seems certain to increase. However, among the most coveted 18-to-34-year-old demographic, the acceptance appears to be increasingly widespread.
Millennials are about three times and Gen Z about four times more likely to use cannabis than aging Boomers. Seeing the numbers, savvy cannabis companies are moving forward full speed in product and brand development to capture this coveted demographic and market share, now and for decades to come. As public perceptions change and legalization increases, the number of users is certain to skyrocket in an essentially untapped market. A global transition is already underway. Growth trajectory is virtually vertical, presenting a once-in-a-generation investment opportunity.
Retail Reach
Founded in 2012 as a private company, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) went public in 2014 and has seen impressive growth since day one. Wildflower is an integrated health-and-wellness company creating distinct brands that incorporate the synergistic effects of plants and their extracts. The company’s latest quarterly sales set records, up 78% over the previous quarter, validating corporate strategy, the popularity of its products and the continued expansion of market share. Intent on boosting revenue and earnings even further, Wildflower is about to finalize the acquisition of a preeminent cannabis retailer in Vancouver that also owns multiple cannabis licenses.
Wildflower’s latest press release is further evidence of the company’s rapid growth and global reach. The company reported third-quarter sales were up by 78% over the second quarter, the 11th consecutive quarter of revenue growth, since Wildflower Brands began selling products. On top of these stellar results the company is further expanding its retail footprint and product distribution with the accretive acquisition of Vancouver-based City Cannabis Corp.
City Cannabis is a premier cannabis retailer holding two of the three City of Vancouver licenses to sell cannabis and is the only company with multiple licenses in British Columbia. With margins of 50%, City Cannabis had revenues of $1.8 million for the reporting period that began with the opening of its two stores in early January. The combined quarterly revenues of Wildflower Brands and City Cannabis equates to an impressive $4.3 million. Wildflower expects to close on the City Cannabis deal before the end of June, and the acquisition will immediately be accretive to Wildflower’s earnings upon closing.
Bringing City Cannabis and Wildflower together will result in revenue operations in three U.S. states and two Canadian provinces with a combined North American target market of more than 75 million people. The positive net income generated by City Cannabis comes from just two operating properties, even though the company holds an additional seven leases at various stages of permitting approvals.
Commenting on the financials, Wildflower CEO William MacLean stated, “We are pleased with the financial results of both Wildflower and City Cannabis. Sales through every Wildflower distribution channel are up, and sales at City’s licensed retail outlets continue to grow month over month. The positive net income is particularly impressive with City Cannabis carrying a total of nine leases, which are at various stages of the permitting process.”
Grow, Grow, Grow
Already a solid presence in California, Wildflower owns 14 cannabis licenses for recreational and medical cannabis cultivation, manufacturing, retail distribution and delivery. Wildflower’s expansion into Canada with the acquisition of City Cannabis strengthens the company’s global growth strategy, which includes strategic distribution deals already in place in the European Union and South Africa. In addition to capturing revenues from retail operations, the City acquisition gives Wildflower another channel to market its enormously popular products and launch into the over-the-counter market with its CBD formulations and accessories.
Wildflower continues to capture ever-greater market share with innovation, retail expansion and a growing family of popular brands. The company’s strategic partnerships, acquisitions and organic growth are all bolstered by its marketing genius to lock in more loyal consumers. Grabbing national and celebrity attention, Wildflower used ingenious product placement during the 2019 Oscars by including its CBD+ Healing Stick in each of the gift bags of the stars.
The company has also employed an innovative pop-up store approach in SoHo, New York, to introduce Wildflower Wellness products. Wildflower identified a compatible high-profile retail venue and struck a deal with the outlet, then marketed its products in the upscale establishment for a limited time period, raising market uptake and visibility.
Big Names
In addition to fourth-quarter growth, Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) reported increased revenue generation from two states to five states by operationalizing both consumer packaged goods and retail business units, including strong branded products distribution and the opening of seven new Rise™ stores nationwide. “In just six months following our RTO in June and in the beginning of 2019, we have expanded the infrastructure for our consumer products and retail businesses to now include 13 production facilities and the ability to open 88 retail locations across 12 states including pending acquisitions,” said GTI founder and COE Ben Kovler. “At the same time, we have built an incredible team that is over 500 strong to support our strategy to distribute brands at scale. With the growth of our branded product distribution, new store openings and adult-use markets coming on line, we are very pleased to have more than tripled our revenues from one year ago both year-over-year and quarter-over-quarter.”
Scotts Miracle-Gro Company (NYSE: SMG) earns its spot as a marijuana stock thanks to the company's Hawthorne Gardening subsidiary, which ranks as the top supplier of hydroponic gardening products to the U.S. cannabis industry. In Scotts' fiscal 2019 first quarter, this business contributed 47% of the company's total revenue. SMG notes that each state’s cannabis industry and regulatory system are still in the process of maturing and says that “our experience growing an expansive, thriving business enterprise, and the company’s history of collaborating with government entities and other stakeholders to address difficult regulatory issues can provide invaluable insight and expertise to officials grappling with the challenges inherent in building comprehensive regulation for the cannabis industry. We are committed to working with regulatory bodies at all levels of government to help achieve these goals.”
Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF), a vertically integrated "seed-to-sale" company and the first and largest fully licensed medical cannabis company in the State of Florida, achieved its goal of reaching 30 stores by end of Q2 with 28 Trulieve dispensary locations operating in Florida, one in California, and one added through its Connecticut acquisition. As noted in announcing its first-quarter results, Trulieve estimates that its expansion into Massachusetts, along with its continued growth in Florida, Connecticut and California, will push 2020 revenues in the range of $380 million-to $400 million, generating $140 million-$160 million in adjusted EBITDA. "Our first quarter results reflect our ability to deliver on our strategic initiatives, translating into continued strong financial performance," said CEO Kim Rivers. "In addition to delivering on strong financial results we also achieved many significant milestones in the first quarter of the year. Growth continued in Florida with the opening of four new dispensaries, completing the first sale of smokable flower in Florida, and settling with the Florida Department of Health, allowing us an additional 14 stores above the state cap..."
Acreage Holdings Inc. (CSE: ACRG) (OTCQX: ACRGF) is gaining ground as it works toward increasing its national footprint and expanding in the western United States. Despite delayed dispensary openings caused by local regulators in both Massachusetts and Ohio, the company grew its Q1 revenues by 487%. The company is also on the fringe of an acquisition by Canopy Growth (TSX: WEED) (NYSE: CGC), a move Acreage founder, CEO and Chairman Kevin Murphy said “will provide us the ability to rapidly accelerate our growth plan as the transaction makes us the most attractive partner in U.S. cannabis.” Shareholders from both companies are voting on Canopy Growth’s potential acquisition of Acreage expected to “create greater shareholder value than as competitors in the U.S.”
Skepticism about the cannabis has disappeared; there’s little question about either the viability or the profitability of the newly respected cannabis sector. Significant money has already been made in the nascent industry, and it appears that a plethora of new winners will be created in the burgeoning sector.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Searching for the Next Super Nova
CannabisNewsWire Editorial Coverage: Skepticism has been squashed and all apprehension eliminated. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?
Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Last October Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) soared 60% in one week when the company announced a deal to buy PharmCann. Florida-based Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL) went public last September through a reverse merger in Canada and soared 200% after a strong 2018 Q2. Already up big on Canadian exchanges, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) became the first pure-play marijuana stock to list on NASDAQ around $7 and just bounced off $23 a share. Last year, Tilray Inc. (NASDAQ: TLRY) became the first cannabis company to IPO on the NASDAQ at $17 per share and by September skyrocketed to $300. Despite price surges and fluctuations in the big cannabis names, there’s bound to be more money made in the sector; the run is far from over.
- Cannabis run is far from over, new winners emerging
- Branding, marketing and retail reach signals of success
- Quarter-over-quarter revenue increase helps identify future potential
To view an infographic of this editorial, click here.
Good Times Have Just Begun
Legal cannabis is a recent global phenomenon, and the emergent market appears to be nowhere near reaching its potential. The worldwide legal marijuana market, valued at just $9.3 billion in 2016, is expected to blow past $146 billion within the next six years.
According to a United Nations report, cannabis is the most widely consumed drug on the planet. Approximately 270 million global consumers use cannabis, equivalent to about 4% of the world’s population and a mere pittance in market penetration. As marijuana muscles into the mainstream, usage among all age groups is on the upswing. However, among the most coveted 18-to-34-year-old demographic, there’s an explosion of acceptance as they mature in a world where cannabis is common.
Millennials are about three times and Gen Z about four times more likely to use cannabis than aging Boomers. Forward-leaning cannabis companies are full throttle in product and brand development to corral this coveted demographic and capture market share, now and for decades to come. As public perceptions change and legalization expands, the number of users is certain to skyrocket in an essentially untapped market. A global transition is underway, and the good times for cannabis have just begun. Growth trajectory is virtually vertical, presenting a once-in-a-generation investment opportunity.
Retail Reach
Founded in 2012 as a private company, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) went public in 2014 and has been on a tear ever since. Wildflower is an integrated health-and-wellness company creating distinct brands that incorporate the synergistic effects of plants and their extracts. The company’s latest quarterly sales set records, up 78% over the previous quarter, validating corporate strategy, the popularity of its products, and the continued expansion of market share. Intent on supercharging revenue and earnings even further, Wildflower is about to finalize the acquisition of a preeminent cannabis retailer in Vancouver that also owns multiple cannabis licenses.
Wildflower’s latest press release is further evidence of the company’s rapid growth and global reach. The company reported third-quarter sales were up by 78% over the second quarter, the 11th consecutive quarter of revenue growth, since Wildflower Brands began selling products. On top of these stellar results the company is further expanding its retail footprint and product distribution with the accretive acquisition of Vancouver-based City Cannabis Corp.
City Cannabis is a premier cannabis retailer holding two of the three City of Vancouver licenses to sell cannabis and os the only company with multiple licenses in British Columbia. With margins of 50%, City Cannabis had revenues of $1.8 million for the reporting period that began with the opening of its two stores in early January. The combined quarterly revenues of Wildflower Brands and City Cannabis equates to an impressive $4.3 million. Wildflower expects to close on the City Cannabis deal before the end of June, and the acquisition will immediately be accretive to Wildflower’s earnings upon closing.
Bringing City Cannabis and Wildflower together will result in revenue operations in three U.S. states and two Canadian provinces with a combined North American target market of more than 75 million people. The positive net income generated by City Cannabis comes from just two operating properties, even though the company holds an additional seven leases at various stages of permitting approvals.
Commenting on the financials, Wildflower CEO William MacLean stated, “We are pleased with the financial results of both Wildflower and City Cannabis. Sales through every Wildflower distribution channel are up, and sales at City’s licensed retail outlets continue to grow month over month. The positive net income is particularly impressive with City Cannabis carrying a total of nine leases, which are at various stages of the permitting process.”
Grow, Grow, Grow
Already an established presence in California, Wildflower owns 14 cannabis licenses for recreational and medical cannabis cultivation, manufacturing, retail distribution and delivery. The company’s expansion into Canada with the acquisition of City Cannabis bolsters Wildflower’s global growth strategy, which is includes strategic distribution deals already in place in the European Union and South Africa. In addition to capturing revenues from retail operations, the City acquisition gives Wildflower another channel to market its enormously popular products and launch into the over-the-counter market with its CBD formulations and accessories.
Wildflower continues to capture ever-greater market share with innovation, retail expansion and a growing family of popular brands. The company’s strategic partnerships, acquisitions and organic growth are all bolstered by its marketing genius to lock in more loyal consumers. Grabbing national and celebrity attention, Wildflower used ingenious product placement during the 2019 Oscars by including its CBD+ Healing Stick in each of the gift bags of the stars.
The company has also employed an innovative pop-up store approach in SoHo, New York, to introduce Wildflower Wellness products. Wildflower identified a compatible high-profile retail venue and struck a deal with the outlet, then marketed its products in the upscale establishment for a limited time period, raising market uptake and visibility.
Big Names
Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) is a cannabis retailer with operations across the United States and flagship stores in Los Angeles, Las Vegas and New York. Company objectives are to capitalize on first-mover advantage by opening stores in top markets and building brand awareness and customer acquisition. The company is also intent on expanding retail footprint and creating an omnichannel consumer experience.
Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL) is a vertically integrated, seed-to-sale company and is the first and largest fully licensed medical-cannabis company in Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the state, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is a global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. The company is committed to responsibly elevate the consumer experience and is building an iconic brand portfolio.
Tilray Inc. (NASDAQ: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids. The company currently serves tens of thousands of patients and consumers in 12 countries spanning 5 continents. Tilray was the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP) certified in accordance with European Medicine Agency (EMA) standards.
The cannabis markets have already produced some amazing profits, but all indications are the industry is only at the beginning of an amazing ascent. There’s little doubt that a plethora of new winners will be created in the burgeoning sector. When searching for the next super nova, Wildflower Brands is certainly one to watch.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Growing Media Coverage, Celebrity Endorsements Lead to Soaring CBD Popularity
CannabisNewsWire Editorial Coverage: Growing media attention and celebrity acceptance is fueling rising popularity of CBD.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is one of the companies benefiting most from this attention, with its products featured in Kim Kardashian’s baby shower and the new Saks CBD salon. Aurora Cannabis Inc. (NYSE: ACB) is working with the UFC (Ultimate Fighting Championship) and its athletes in clinical studies involving pain management, inflammation, injury, exercise recovery and mental well-being. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) recently acquired Beboe, a luxury cannabis brand founded in California. With this growing CBD popularity, HEXO Corp. (NYSE American: HEXO) announced that it has become the first cannabis company to join Food & Consumer Products of Canada (FCPC), the largest voice of the Canadian food, beverage and consumer products industry. And Aphria Inc. (TSX: APHA) (NYSE: APHA) has been awarded a fifth lot for the cultivation of medical cannabis in Germany as part of the company’s previously awarded license from the German Federal Institute for Drugs and Medical Devices.
- Kim Kardashian’s CBD-themed baby shower splashed across business wires, tabloids, and social media.
- High-profile appearances and placement are boosting upper-end CBD brands.
- Broad media coverage is normalizing and drawing ever more customers to the sector.
To view an infographic of this editorial, click here.
CBD Whips Up Media Storm
Recent months have seen CBD in the media spotlight more than ever before. The relaxing natural compound, derived from hemp and cannabis plants but without the psychoactive qualities of THC, has been grabbing attention across the internet and in print and broadcast media. What was a fringe interest only a few years ago has now grown into the subject of unceasing mainstream attention.
Some of the coverage comes from news reports and opinion pieces, while the recent legalization of hemp in the United States has sparked interest from virtually every sector of society. With CBD products now on sale in a growing number of shops across a growing number of states, attention has also come from social media influencers, fashionistas and lifestyle writers. Even celebrities and athletes are in on the act, with CBD products appearing in the hands of the rich and famous — a sure signal of widespread popularity in the media age.
Garnering Celebrity Support
One of the brands reaping the benefits from this flurry of media attention is Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a premier creator and marketer of plant-based health and wellness products. Headquartered in Vancouver, British Columbia, Wildflower has rapidly expanded its footprint out of Canada and into the United States as the country has become increasingly hospitable to CBD products. The company is focused on building brands around plant-based products, appealing to those looking for natural way to relieve pain, relax and be healthy.
CBD is an important part of Wildflower’s stable of brands. Its Wildflower Wellness brand provides capsules, tinctures, vaporizing liquid and other CBD-infused products, all designed to support relaxation, health and wellness. With its unique combination of high-quality, effective natural products, the brand is designed to appeal to those looking to escape the stresses of modern life and has been embraced by consumers through North America.
Little wonder Wildflower products showed up at Kim Kardashian’s recent baby shower. Kardashian and her husband, Kanye West, recently welcomed their fourth child — and second born by surrogate. In preparation for the event, Kardashian threw an extravagant and well-reported baby shower. To help guests relax and prepare to celebrate the “calm before the baby storm,” the Keeping Up with The Kardashians star threw a CBD-themed baby shower, featuring a DIY makeup station and a group session sound bath. The event included such tranquil activities as massages, flower arranging and mixing CBD oils to create personalize shower gifts.
As part of the event, Kardashian encouraged her guests to enjoy a relaxing puff of Wildflower’s vaporized CBD products. A Wildflower vaporizer was featured in pictures from the party, as celebrities made the most of what CBD has to offer.
This isn’t the first time that Wildflower products have found their way into celebrity hands. Wildflower goods were selected for inclusion in the 2019 Four Seasons Hotel Hollywood Swag Bags, given to nominees, presenters and actors staying at the hotel for this year’s Oscars. With CBD becoming not just acceptable but fashionable, Wildflower was a natural fit for a hotel wanting to make a good impression on its celebrity guests.
The cachet of CBD as a prestigious, high-profile consumer product has been further reinforced by the creation of a CBD salon within the shop at Saks Fifth Avenue. Directly connecting CBD with other high-end brands and the concept of luxury shopping firmly stakes out CBD’s place within the luxury goods market. And once again, Wildflower has garnered high-profile visibility among the products on display.
Media Eyes Up CBD
This move into celebrity culture and the high-end shopping market has come alongside growing media attention for CBD brands.
The arrival in Los Angeles of prominent Long Island beauty boutique Botanica Bazaar gave Vogue reason to cover a range of products including CBD tinctures. For this part of the article, the magazine focused on Wildflower’s products. The company’s strongest CBD remedies, its tinctures have been designed to counter one of the big problems with cannabinoid products — the sometimes unpleasant taste. Wildflower has tackled this challenge by adding natural flavorings to create a product that’s recognized for its flavor as well as its relaxing qualities.
The Vogue piece garnered positive coverage for CBD in general, with Botanica Bazaar’s owners talking about how the pain-relieving power of these products had won a growing number of loyal customers. The article also provided even more positive coverage for Wildflower, with the writers noting that “Wildflower’s CBD tinctures and vapes not only kill the aesthetics game, but also taste good.”
Coverage of broader cannabis culture has brought CBD brands to the attention of a receptive audience. When Vice presented an article on the best female-owned brands in the cannabis sector, the magazine included Wildflower in a section on pain-relieving spa products. A pain-relief product designed to tackle muscle, joint and back pain, the CBD+ Healing Stick was recommended in the article as a useful cure for menstrual pain.
Buzzfeed went so far as to publish an article on why readers should be buying CBD Christmas gifts for everyone, including featured recommendations for products their readers might want to pick. These included a lip butter, truffles and CBD-infused sparkling water, showing the wide range of options now available to the CBD consumer.
Wildflower once again stole the limelight. The company’s disposable CBD vaporizer pen proved to be just too good to leave out of the recommendations. All in all, the company has received mention in more than 15 different articles and media pieces, touting Wildflower and singing the praises of their CBD products.
CBD’s Growing Press Presence
It seems like hemp and CBD can’t help but make news. And other companies besides Wildflower are enjoying the media attention.
Aurora Cannabis Inc. (NYSE: ACB) has begun an exclusive, multiyear, multimillion dollar, global partnership with UFC to advance CBD research. The Edmonton-based cannabis producer said it will work with the fight league’s athletes to study the effectiveness of the plant in treating pain management, inflammation, injury, exercise recovery, and mental well-being. “This global partnership places focus squarely on the health and well-being of UFC's talented and highly trained athletes,” said Aurora CEO Terry Booth. “The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business.”
With its acquisition of Beboe, Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) gains geographic exposure to the California and Colorado markets, as well as a high-end luxury brand to fill out its brand portfolio. Beboe was founded by fashion executive Clement Kwan and celebrity tattoo artist Scott Campbell and has been dubbed the "Hermes of marijuana" by The New York Times. Beboe products, which include rose-gold vaporizer pens, edibles, and CBD-infused drinks, have already earned their way into 125 retail locations in California and Colorado, and the company had already signed a deal with luxury department store Barney's New York to open a luxury store called the High End, which opened on the fifth floor of Barney's flagship Beverly Hills store in late March.
As the first cannabis company to join FCPC, HEXO Corp. (NYSE American: HEXO) continues on its journey to bring its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies. “HEXO is thrilled to be the first cannabis company to join the Food & Consumer Products of Canada, an established and industry leading association in the consumer-packaged goods space,” said HEXO co-founder and CEO Sébastien St. Louis. “We look forward to working with FCPC and all their members to forge new relationships and potential partnerships. It is an exciting time to be in the ever-evolving cannabis industry.”
Aphria Inc. (TSX: APHA) (NYSE: APHA) was provisionally awarded the fifth cultivation lot in Germany through its subsidiary, Aphria Deutschland GmbH, or Aphria Germany. The lot was secured following a review by a German court, which affirmed the BfArM’s decision. Aphria Germany has now won the maximum output from the German tender process — a total of five lots — and is the only licensed producer in Germany with permission to grow all three strains of medical cannabis approved by the BfArM.
As CBD’s cultural presence grows, companies with a strong media presence and the attention of celebrities and athletes seem certain to benefit.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Celebrity Attention Fuels Rising Press Profile of CBD
CannabisNewsWire Editorial Coverage: Companies with a presence in the CBD market are seeing their profiles rise, thanks to growing media and celebrity attention.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is one of the companies benefiting most from this attention, with its products featured in Kim Kardashian’s baby shower and the new Saks CBD store. Tilray Inc. (NASDAQ: TLRY) has seen strong market coverage as its shares rose following action to tackle product shortages in Canada. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has fostered its public profile through efforts by the company’s media-savvy co-CEO. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) drew attention as its share value rose with a large external investment. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) has been focusing on growing better CBD-producing plants, work that has drawn attention to its VP of cultivation.
- Kim Kardashian’s CBD-themed baby shower drew attention to the range of relaxing CBD products.
- Other high-profile appearances are boosting upper-end CBD brands.
- Broad media coverage is normalizing and drawing customers to the sector.
To view an infographic of this editorial, click here.
CBD Whips Up Media Storm
Recent months have seen CBD in the media spotlight more than ever before. The relaxing natural compound, derived from hemp and cannabis plants but without the psychoactive qualities of THC, has been grabbing attention across the internet and in print and broadcast media. What was a fringe interest only a few years ago has now grown into the subject of huge mainstream attention.
Some of the coverage comes in news and opinion pieces, where the recent legalization of hemp in the United States has driven a surge in interest. But with CBD products on sale in a growing number of shops across a growing number of states, attention has also come from fashion and lifestyle writers. Even celebrities are in on the act, with CBD products appearing in the hands of the rich and famous — a seemingly sure omen of popularity in the media age.
Garnering Celebrity Support
One of the brands that has benefited strongly from this flurry of media attention is Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a creator of health and wellness products. Headquartered in Vancouver, British Columbia, Wildflower has reached out of Canada and into the United States as North America has become increasingly hospitable to CBD products. The company is focused on building brands around plant-based products, appealing to those looking for natural way to relax and be healthy.
CBD is an important part of Wildflower’s stable of brands. Its Wildflower Wellness brand provides capsules, tinctures, vaporizing liquid and other CBD-infused products, all designed to support relaxation, health and wellness. With its combination of effectiveness and natural products, the brand is, like many others in the CBD sphere, designed to appeal to those looking to escape the stresses of modern life.
That’s presumably how Wildflower products came to appear at Kim Kardashian’s recent baby shower. Kardashian and her husband, Kanye West, recently welcomed their fourth child — and second born by surrogate. In preparation for the event, Kardashian threw an extravagant and well-reported baby shower. To help her guests escape the stresses of life and to prepare her celebrate the “calm before the baby storm,” the celebrity themed her baby shower around the relaxing power of CBD. The event included such tranquil activities as massages, flower arranging and mixing CBD oils to create personalize shower gifts.
As part of the event, Kardashian encouraged her guests to enjoy a relaxing puff of CBD, and Wildflower’s vaporizing products were on hand to provide this opportunity. A Wildflower vaporizer appeared in pictures from the party, as celebrities made the most of what CBD has to offer.
This isn’t the first time that Wildflower products have found their way into celebrity hands. Wildflower goods were selected for inclusion in the 2019 Four Seasons Hotel Hollywood Swag Bags, given to nominees, presenters and actors staying at the hotel for this year’s Oscars. With CBD becoming not just acceptable but fashionable, Wildflower was a natural fit for a hotel wanting to make a good impression on its celebrity guests.
The image of CBD as a prestigious, high-profile consumer luxury has been further reinforced by the creation of a CBD shop within the shop at Saks Fifth Avenue. Directly connecting CBD with other high-end brands and the concept of luxury shopping, this move firmly stakes out CBD’s place within the luxury goods market. And once again, Wildflower is visible among the products on display.
Media Eyes Up CBD
This move into the celebrity culture and the high-end shopping market has come alongside growing media attention for CBD brands.
The arrival in Los Angeles of prominent Long Island beauty boutique Botanica Bazaar gave Vogue reason to cover a range of products including CBD tinctures. For this part of the article, the magazine focused on Wildflower’s products. The company’s strongest CBD remedies, its tinctures have been designed to counter one of the big problems with cannabinoid products — the sometimes unpleasant taste. Wildflower has tackled this challenge by adding natural flavorings to create a product that’s recognized for its flavor as well as its relaxing qualities.
The Vogue piece garnered positive coverage for CBD in general, with Botanica Bazaar’s owners talking about how the pain-relieving power of these products had won a growing number of loyal customers. The article also provided positive coverage for Wildflower, with the writers noting that “Wildflower’s CBD tinctures and vapes not only kill the aesthetics game, but also taste good.”
Coverage of broader cannabis culture has brought CBD brands to the attention of a receptive audience. When Vice presented an article on the best female-owned brands in the cannabis sector, the magazine included Wildflower in a section on pain-relieving spa products. A pain-relief product designed to tackle muscle, joint and back pain, the CBD+ Healing Stick was recommended in the article as a useful cure for period pain.
Buzzfeed went so far as to publish an article on why readers should be buying CBD Christmas gifts for everyone, including featuring recommendations for products their readers might want to pick. These included a lip butter, truffles and CBD-infused sparkling water, showing the wide range of options now available to the CBD consumer.
Wildflower once again stole some of the limelight. The company’s disposable CBD vaporizer pen proved too good a novelty to leave out of the selection. All in all, the company has received mention in more than 15 different articles and media pieces, touting Wildflower products and singing the praises of CBD in general.
CBD’s Growing Press Presence
It seems like hemp and CBD can’t help but make news.
Canadian company Tilray Inc. (NASDAQ: TLRY), a world leader in the field of cannabis and cannabinoids, hit the headlines in Investor’s Business Daily after it announced its stock had jumped based on first-quarter sales. Like many companies in Canada, Tilray has been struggling to meet demand following the legalization of recreational cannabis. However, the company has responded swiftly to the supply shortage, investing $32.6 million to expand it cultivation and manufacturing space by nearly 20%, a move that should keep its profile high.
Another of the big cannabis companies, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has built up its profile partly through the work of co-CEO Mark Zekulin. The more outward-facing of the company’s two CEOs, Zekulin has courted public attention through media appearances such as a recent interview with Market Watch. The fact that Canopy Growth is one of the biggest cannabis companies in one of the biggest cannabis markets doesn’t hurt either. This drew the attention of drinks giant Constellation Brands, which invested billions in the company with an eye to products such as CBD drinks; the move made headlines across the business world. A push into the United States with a new hemp-growing facility in New York state has further raised the company’s public profile.
Some of the media coverage around cannabis and CBD has an air of incredulity to it. When Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) saw its share price rise despite first-quarter losses, it inevitably drew attention from market commentators. An investment of C$2.4 billion from tobacco giant Altria is undoubtedly a major factor in the company’s strong performance despite setbacks. Such investments promise future developments, and market commentators watch eagerly to see what will happen next.
Within the United States, CBD producer Charlotte’s Web Holdings Inc. (OTC: CWBHF) (CSE: CWEB) has gained attention as a business with an unpretentious brand and a strong scientific grounding to its products. Using proprietary genetics, the company is working to produce high-quality, low-cost hemp to meet the demands of an increasingly large market. Charlotte’s Web has also won attention for its vice president of cultivation, Jared Stanley, who was recently featured in a list of the hundred most influential figures in the cannabis industry.
As CBD’s cultural presence grows, companies with a strong media presence and the attention of celebrities seem certain to benefit.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Untapped Cannabis Market Offers Spectacular Growth Opportunities
CannabisNewsWire Editorial Coverage: The explosive growth recently seen in the cannabis industry presents a rare chance for savvy companies to profit in a virtually untapped market.
- Legal marijuana market projected to reach $146.4 billion.
- United States and Canada current epicenter of cannabis growth.
- Brand recognition and retail reach imperative for market share.
The cannabis bonanza has created a rare window of opportunity for companies that are able to capture market share and create long-term success. Brand recognition and retail reach look to be key to obtaining these lucrative rewards. Shortly after posting its tenth consecutive quarter of increased revenues, Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) announced intentions to further expand its footprint with the acquisition of premier licensed cannabis retailer, City Cannabis Corp. A finalized accretive acquisition will add significant revenues to Wildflower, providing access to several valuable cannabis licenses in lucrative premium locations. Other companies in the sector are also looking to grow in the market through a variety of promising ways. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) announced it has entered into a binding letter agreement with Hempco Food and Fiber Inc. to acquire all of the issued and outstanding common shares of Hempco not already owned by Aurora. Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE: GTII) has closed on the acquisition of Los Angeles-based For Success Holding Company, the creator of Beboe branded cannabis products. Acreage Holdings Inc. (OTCQX: ACRGF) (CSE: ACRG) announced that it has entered into a definitive arrangement agreement that grants Canopy Growth the right to acquire 100% of its shares. And as part of its strategy to become a multistate operator, Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) (CHOOF Profile) has signed a letter of intent to purchase a 95% equity interest in a Florida-based vertically integrated cannabis applicant.
To view an infographic of this editorial, click here.
Extraordinary Market Development
The extraordinary development of the cannabis industry can be tied at least in part to a wave of public support that has turned into overwhelming acceptance. Fifteen years ago, only a third of Americans were in favor of federal legalization of marijuana. Today, an estimated two-thirds of Americans support legalization, up from only 54% two years ago. Among adults under age 35, a whopping 85% favor federal legalization. Public acceptance gained so much momentum so fast that the cannabis industry is struggling to meet the demand. As the cannabis industry and markets mature, acquisition and consolidation announcements have become almost daily occurrences.
The global legal marijuana market, valued at $9.3 billion in 2016, is expected to reach $146.4 billion by the end of 2025, an incredible 16-fold increase over nine years. Legal cannabis markets are still relatively new, and the market is nowhere near its total sales potential. An estimated 272 million global consumers use cannabis, equivalent to only about 4% of the world’s population. Staggering increases in those numbers appear to be all but certain. Perhaps nowhere is this hyper-growth more spectacular than North America. Wall Street's top cannabis analyst forecasts the U.S. market to grow to $80 billion by 2030 assuming national availability.
Center for Growth
Cannabis demand is even greater north of the border. The industry has been facing cannabis supply shortages ever since recreational cannabis was legalized across Canada. For example, the cannabis market in country’s westernmost province, British Columbia, registered slightly over CA$19 million in legal cannabis sales in 2018, but that number is projected expected to explode to CA$722 million in annual sales in the next five years by — a mind-boggling 37-fold increase over six years.
Pegged to soar nearly 3,700% by 2024, British Columbia is an ideal center for cannabis growth. Headquartered in the heart of this upsurge, Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) has already staked out an enviable market position and is further expanding its retail footprint and product distribution in the province. The company announced that it intends to acquire City Cannabis Corp. in an all-stock deal.
Holding two of the three City of Vancouver licenses to sell cannabis, City Cannabis is a premier cannabis retailer and the only company with multiple licenses in British Columbia. The Letter of Intent looks to solidify Wildflower’s position as a high-profile retail outlet of premium brands generating millions in revenues right in the heart of the B.C. cannabis boom.
“City Cannabis and Wildflower are the perfect combination of premier products and a premier consumer retail experience,” said Wildflower CEO William MacLean. “City Cannabis’ retail consumer data and insight will help shape development of Wildflower’s product line-up while the retail expertise of City Cannabis will aid Wildflower in its retail expansion. The combination of Wildflower and City Cannabis will form a truly global cannabis company.”
First established in British Columbia in 2012, Wildflower now has a retail reach that extends from Vancouver to New York. Wildflower Brands is constantly expanding development, design, marketing and retail distribution of its branded products in the cannabis sector. The company launched into Washington State in 2016 and has seen consistent growth ever since.
Creating a Global Brand
Today Wildflower markets its distinctive CBD+ products to more than 300 retailers in the health and wellness sector and operates in regulated cannabis markets throughout North America in accordance with jurisdictional regulations for THC and CBD+ products. Wildflower’s unique and holistic products are developed and manufactured at the company’s U.S.-based GMP facilities, tested by a third-party lab and backed by a 100%-satisfaction guarantee.
Each Wildflower product is synergistically formulated to create a unified global wellness brand. For example, Wildflower’s highly recognized Wildflower Wellness brand offers a broad array of hemp-based, full-spectrum, CBD-infused products from vaporizers and capsules to tinctures, soaps and topicals.
The company’s King Recharge is on the cutting edge of cannabis technology and delivery systems with its King Extracts, a sleek, rechargeable vaporizer offering five popular CBD strains and a unique pocket-sized charging and storage case.
Closely associated with select hospital oncology departments, Exclusive is Wildflower’s Los Angeles-based dispensary of premium cannabis products. Wildflower already owns 14 cannabis licenses in California for recreational and medical cannabis cultivation, manufacturing, distribution, retail and delivery. Activating all these licenses could be a jackpot for the company, driving revenues while minimizing risk.
Expansion into Canada with the acquisition of City Cannabis is the next step in Wildflower’s global strategy. The thriving retail outlet, with licenses for several more locations, provides Wildflower with a high-profile presence in what may be one of the greatest growth markets in the world. Wildflower plans to market its enormously successful products through the outlet and launch into the over-the-counter market with its CBD formulations and accessories.
An Expanding Footprint
Wildflower’s U.S. presence now encompasses more than 200 retailers in Washington state and more than 20 retailers in New York City. The company partnered with Retail Worx to establish shop-in-shop retail locations in the nucleus of New York and open its first Wildflower by Bridges General store.
A clear next move for Wildflower in this partnership is a rollout into other Bridges General’s stores in New York City and San Francisco. Retail distribution in other major U.S. markets includes over 80 wellness and healthcare practitioners and an army of retail stores nationwide numbering in the hundreds. Wildflower is aggressively expanding both brand recognition and retail reach.
Wildflower continues to capture increasing market share with innovation, retail expansion and a growing family of popular brands. The company’s strategic partnerships, acquisitions and organic growth are all strengthened by the company’s focus on creating loyal consumers.
Grabbing national and celebrity attention, Wildflower used ingenious product placement during the 2019 Oscars by including its CBD+ Healing Stick in each of the gift bags of the stars, and Hollywood is embracing the product.
But Wildflower didn’t just aim for the stars. Wildflower launched an infomercial campaign in Phoenix promoting the company’s Wellness’ Cool Stick. And across the country, the company has employed an innovative pop-up store technique in SoHo, New York, to introduce its Wildflower Wellness products. To make this happen, Wildflower identified a compatible high-profile retail venue and struck a deal with the outlet, then marketed its products with fanfare in the upscale establishment for a limited time period, raising market uptake and visibility.
Clearly Wildflower seems to be on a mission to create a global cannabis enterprise. With such rapid expansion of brand recognition and retail distribution, Wildflower is firmly establishing its hold on the cannabis bonanza.
Buying Up Cannabis
And Wildflower isn’t alone in focusing on the booming cannabis business. Several market leaders have announced recent moves designed to strengthen their positions in the sector.
With its acquisition of the remaining common shares of Hempco, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) gains low-cost, high-volume access to hemp for the extraction of CBD, a component that has been recognized for its therapeutic benefits across a wide range of medical indications and wellness applications. Aurora recognized this potential early, investing in Hempco as early as 2017. The company subsequently expanded its hemp-based infrastructure through the acquisitions of Agropro, Borela and ICC Labs.
By acquiring the Beboe product line, Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE: GTII) reinforces its commitment to provide nationwide access to safe and effective cannabis. “The meticulously crafted suite of Beboe products supports the premium segment within GTI’s brand portfolio and is firmly aligned with our long-term growth strategy,” said GTI founder and CEO Ben Kovler. “Beboe has an extremely talented team, a robust innovation pipeline, an aligned vision on the future of cannabis and a ground-breaking partnership with Barneys New York. We are thrilled to have the visionary Beboe team officially on board with GTI.”
Acreage Holdings Inc.’s (OTCQX: ACRGF) CSE: ACRG) agreement with Canopy Growth gives CGC the right to acquire 100% of the shares of Acreage, with a requirement to do so when cannabis production and sale becomes federally legal in the United States. "From the first day we created our company, providing exceptional customer care and delivering shareholder value have been our top priorities,” said Acreage Holdings chairman, CEO and president Kevin Murphy. “This transaction will help accomplish both. When the right is exercised, having access to Canopy Growth's deep resources will enable us to innovate, develop and distribute quality cannabis brands across the U.S. and continue expanding our U.S. footprint. At the same time, a confluence of factors is making it much more difficult for a multi-state operator to achieve its full potential, including the enormous amount of cash required to scale. Our Board of Directors, management team and I are pleased to deliver significantly increased liquidity to our shareholders and put ourselves in an even stronger position to deliver continued and significant upside."
An emerging adult and medical use cannabis company that has secured one of the largest national retail networks in Canada, Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) is looking to expand into Florida. The cannabis applicant at the heart of the company’s equity interest agreement is progressing on its master license application to operate up to 25 retail locations as well as a microprocessing and cultivation facility for medical purposes. Upon completion of the transaction, Choom will use its medical brand, Clarity Medical Centres, to create a network of branded medical marijuana treatment centers.
Some have called what is happening now in the cannabis sector a once-in-a-generation opportunity and predict that this is the start of a decade-long cannabis bull market. All indications point to those predictions being correct.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
The Cannabis Bonanza Has Just Begun
CannabisNewsWire Editorial Coverage: The cannabis industry presents a rare opportunity to profit from spectacular growth in a virtually untapped market.
- Legal marijuana market projected to reach $146.4 billion.
- United States and Canada current epicenter of cannabis growth.
- Brand recognition and retail reach imperative for market share.
Capturing market share and creating long-term success in this explosive market will require brand recognition and retail reach. Shortly after posting its tenth consecutive quarter of increased revenues, Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) announced intentions to further expand its footprint with the acquisition of premier licensed cannabis retailer, City Cannabis Corp. A finalized accretive acquisition will add significant revenues to Wildflower, providing access to several valuable cannabis licenses in lucrative premium locations. Other companies in the sector are looking to grow in the market through other promising ways. Tilray Inc. (NASDAQ: TLRY) recently acquired Natura Naturals Holdings, boosting capacity to supply cannabis products across Canada. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) bought hemp company AgriNextUSA to accelerate entry into key American jurisdictions. Medmen Enterprises Inc. (OTCQX: MMNFF) (CSE: MMEN) announced the purchase of two vertically integrated operations, which include retail locations and 25,000 square feet of cultivation and production capacity. And only two weeks ago, Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) completed the acquisition of Eureka to provide access to California’s wholesale market through a large greenhouse facility.
To view an infographic of this editorial, click here.
Market Frenzy
The sweeping growth of the cannabis industry is rooted at least in part from a groundswell of public support that has turned into a tidal wave of acceptance. Fifteen years ago, only a third of Americans supported federal legalization of marijuana. About two-thirds of Americans now support legalization, up from only 54% two years ago. Among adults under age 35, a whopping 85% favor federal legalization. The movement gained so much momentum so fast that the industry is scrambling to keep up. As the cannabis industry and markets mature, acquisition and consolidation deals appear to be all but certain.
The global legal marijuana market, valued at $9.3 billion in 2016, is expected to reach $146.4 billion by the end of 2025, an incredible 16-fold increase over nine years. Legal cannabis markets are still a relatively new phenomenon, and the market is nowhere near its total sales potential. An estimated 272 million global consumers use cannabis, equivalent to only about 4% of the world’s population. Growth trajectory is virtually vertical. Perhaps nowhere is this hyper-growth more spectacular than North America. Wall Street's top cannabis analyst forecasts the U.S. market to grow to $80 billion by 2030 assuming national availability.
B.C. Center of Boom
Cannabis demand is even greater north of the border. The industry has been struggling with cannabis supply shortages ever since recreational cannabis was legalized across Canada. The country’s westernmost province, British Columbia, is no exception. The B.C. market registered a little over CA$19 million in legal cannabis sales in 2018, but that number is expected to explode to CA$722 million in annual sales by 2024 — a mind-boggling 37-fold increase over six years.
Pegged to soar nearly 3,700% in the next six years, British Columbia is ground zero for cannabis growth. Headquartered at the epicenter of this upsurge, Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) has already staked out an enviable market position and is further expanding its retail footprint and product distribution in the province. The company recently announced that it intends to acquire City Cannabis Corp. in an all-stock deal.
Holding two of the three City of Vancouver licenses to sell cannabis, City Cannabis is a premier cannabis retailer and the only company with multiple licenses in British Columbia. The Letter of Intent looks to solidify Wildflower’s position as a high-profile retail outlet of premium brands generating millions in revenues right in the heart of the B.C. cannabis boom.
“City Cannabis and Wildflower are the perfect combination of premier products and a premier consumer retail experience,” said Wildflower CEO William MacLean. “City Cannabis’ retail consumer data and insight will help shape development of Wildflower’s product line-up while the retail expertise of City Cannabis will aid Wildflower in its retail expansion. The combination of Wildflower and City Cannabis will form a truly global cannabis company.”
Born in British Columbia, Wildflower now has a retail reach that extends from Vancouver to Los Angeles and New York. Established in 2012, Wildflower Brands is constantly expanding development, design, marketing and retail distribution of its branded products in the cannabis sector. The company launched into Washington State in 2016 and has been on a tear ever since.
Creating a Global Brand
Today Wildflower now markets its distinctive CBD+ products to more than 300 retailers in the health and wellness space and operates in regulated cannabis markets throughout North America in accordance with jurisdictional regulations for THC and CBD+ products. Wildflower’s unique and holistic products are developed and manufactured at the company’s U.S.-based GMP facilities, tested by a third-party lab and backed by a 100%-satisfaction guarantee.
Each Wildflower product is synergistically formulated to create a unified global wellness brand. For example, Wildflower’s highly recognized Wildflower Wellness brand offers a broad array of hemp-based, full-spectrum, CBD-infused products from vaporizers and capsules to tinctures, soaps and topicals.
The company’s King Recharge is on the cutting edge of cannabis technology and delivery systems with its King Extracts, a sleek, rechargeable vaporizer offering five popular CBD strains and a unique pocket-sized charging and storage case.
Closely associated with select hospital oncology departments, Exclusive is Wildflower’s Los Angeles-based dispensary of premium cannabis products. Wildflower already owns 14 cannabis licenses in California for recreational and medical cannabis cultivation, manufacturing, distribution, retail and delivery. Activating all these licenses could be a jackpot for the company, driving revenues while minimizing risk.
Expansion into Canada with the acquisition of City Cannabis is the next step in Wildflower’s global strategy. The thriving retail outlet, with licenses for several more locations, provides Wildflower with a high-profile presence in what may be one of the greatest growth markets in the world. Wildflower plans to market its enormously successful products through the outlet and launch into the over-the-counter market with its CBD formulations and accessories.
An Expanding Footprint
Wildflower’s U.S. footprint currently encompasses more than 200 retailers in Washington state and more than 20 retailers in New York City. The company partnered with Retail Worx to establish shop-in-shop retail locations in the nucleus of New York and open its first Wildflower by Bridges General store.
The obvious next step for Wildflower in this partnership is a rollout into other Bridges General’s stores in New York City and San Francisco. Retail distribution in other major U.S. markets includes over 80 wellness and healthcare practitioners and an army of retail stores nationwide numbering more than 300. Wildflower is aggressively expanding both brand recognition and retail reach.
Wildflower continues to capture ever-greater market share with innovation, retail expansion and its growing family of popular brands. The company’s strategic partnerships, acquisitions and organic growth are all bolstered by the company’s marketing genius focused on locking in loyal consumers.
Grabbing national and celebrity attention, Wildflower used ingenious product placement during the 2019 Oscars by including its CBD+ Healing Stick in each of the gift bags of the stars, and Hollywood is embracing the product.
But Wildflower didn’t stop with the stars. To expand exposure into a new target audience, Wildflower launched an infomercial campaign in Phoenix promoting the company’s Wellness’ Cool Stick. And across the country, the company has employed an innovative pop-up store technique in SoHo, New York, to introduce its Wildflower Wellness products. To make this happen, Wildflower identified a compatible high-profile retail venue and struck a deal with the outlet, then marketed its products with fanfare in the upscale establishment for a limited time period, raising market uptake and visibility.
Wildflower is on a mission to create a global cannabis enterprise. With such rapid expansion of brand recognition and retail distribution, Wildflower is carving out its slice of the cannabis bonanza.
Buying Up Cannabis
And Wildflower isn’t alone in focusing on the booming cannabis business. Several market leaders have announced recent moves designed to strengthen their positions in the sector.
Tilray Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation and distribution, has announced the closing of a definitive agreement to acquire all of the issued and outstanding securities of Natura Naturals Holdings Inc., the parent company of a licensed cultivator of cannabis. The acquisition boosts the company’s capacity to supply cannabis products across Canada. Natura’s facility will be renamed High Park Gardens and be used as an additional cultivation facility to serve the medical and adult-use market in Canada.
Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) acquired AgriNextUSA. The acquisition will accelerate Canopy Growth’s entry into key American jurisdictions. “The United States is the next stop on Canopy Growth’s desired path to becoming a leading, revenue-generating company focused on all aspects of cannabinoids and their potential,” said Bruce Linton, co-CEO and Chairman of Canopy Growth.
Medmen Enterprises Inc. (OTCQX: MMNFF) (CSE: MMEN) recently purchased two vertically integrated operations, which include both retail locations and 25,000 square feet of cultivation and production capacity. The company paid a combination of cash and stock valued at an aggregate of $33.5 million. With the closing of the acquisitions, MedMen will be licensed for three medical-use cannabis dispensaries in Arizona.
Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) completed the acquisition of Eureka, which operates a cultivation facility that is developing three dispensaries across California. Curaleaf has the largest footprint of single-branded retail stores in the United States. “The acquisition of Eureka cements our foundation in California and positions us well in the largest cannabis consumption market in the U.S.," said Joseph Lusardi, CEO of Curaleaf.
Some have called the cannabis bonanza a once-in-a-generation opportunity and predict that this is simply the start of a decade-long cannabis bull market that’s only just begun. All indications suggest those predictions may be correct.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Mainstream Acceptance, Strong Growth Adds to Growing CBD Market
CannabisNewsWire Editorial Coverage: The CBD market is experiencing explosive growth as a result of growing mainstream acceptance and strong leadership.
- The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
- Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
- Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.
Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Several companies are responding to the growth by expanding operations. Canadian-based Tilray Inc. (NASDAQ: TLRY) is adding production capacity in both Canada and Europe. Aphria (NYSE: APHA) (TSX: APHA) is increasing its indoor grow operations. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is focusing its development efforts on projects in the United States. And Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is using a significant outside investment to make strategic growth plans.
To view an infographic of this editorial, click here.
Growing Goodness
The CBD market has seen tremendous growth in the past few years, seemingly coming out of nowhere to become a billion-dollar industry. This eye-popping growth has been fueled in large part by CBD’s potential for health and well-being, an area that many researchers are focusing on. Companies have leapt upon the opportunity to offer consumers the benefits associated with cannabis without some of the other issues regularly linked with the drug, including getting users high.
If the past few years have been fruitful, the future looks even brighter for CBD. Soaring sales, growing acceptance within mainstream sports, and the recognized influence of some of the major players within the broader cannabis industry all point to positive movement forward for CBD. And as companies overcome the challenges offered by distributing a previously obscure product to a broad market, the industry looks set to soar.
A Rising Global Market
The growth of the CBD market has so far come mostly out of North America, where the likes of health and wellness company Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) have launched a variety of compelling CBD products. This geographical growth is rooted mostly in legal status, as CBD is extracted either from cannabis or from its nonhigh-inducing form hemp. Though legalization of cannabis remains variable in the United States, hemp is now legal at a national level in both the United States and Canada, with cannabis growth widely permitted.
As a result, the North American cannabis — including CBD — market, has grown in spectacular fashion. The market was worth $9.2 billion in 2017, and estimates project those numbers to reach $47.3 billion by 2027. Savvy companies, such as Wildflower Brands, are paying attention and taking action.
The European CBD market has seen less expansive growth. Within the EU, the range of processed products that can be made incorporating cannabis is more limited, and there’s been less of a concerted push towards legalization for both CBD and cannabis products. Consequently, market growth there has been less impressive.
But that may be about to change, according to analysis from market intelligence firm the Brightfield Group. The company recently predicted 400% growth in the European CBD market from 2018 to 2023, a massive rise in a short five-year span. It looks as if the CBD boom may be set to go global.
Sports and CBD
Cannabis prohibition isn’t the only thing shaping the CBD market. Society’s acceptance of cannabis and CBD cannot be overlooked as a contributing factor. The rules of entities not typically associated with cannabis have sometimes created obstacles to growth in the cannabis sector. But as the legal market develops, those institutions are shifting their attitudes as well.
The sports industry is an ideal illustration of this. During the war on drugs, many teams, leagues and professional organizations took a firm public stance against cannabis, laying down rules that prevented their players from indulging. The NFL, for example, has strict rules against cannabis consumption. Currently, however, former players are campaigning for a change to those rules, not just to allow players access to the same experiences as other people but to tackle issues specifically related to sports.
Recently, cannabis and CBD-infused products, including those such as Wildflower’s topical treatments, have provided a growing number of pain-treatment choices. Given the injuries so frequently seen in professional sports, pain management is crucial. Sports doctors, trainers, coaches and players are always on the lookout for the most effective treatment options. Currently the ban on cannabis and CBD restricts players from choosing such seemingly effective options, fueling the call for change.
Changes could also have a significant impact on the sponsorship side. Currently, only one professional sports team in the United States has a cannabis-related sponsorship, despite the growing wealth and influence of the industry. As barriers come down, the time may come for CBD, much like other recreational and medical products, to gain attention in the sport and beyond through sponsorship and supporter arrangements.
The Challenge of Delivery
This expansion doesn’t come without some challenges. As the market grows and evolves, CBD companies must find ways to distribute products to a sector that didn’t exist a decade ago. The infrastructure most other industries take for granted is being built from scratch.
Fortunately, the companies moving into this space are nimble and flexible, moving quickly to find solutions as they expand and grow. These solutions often include forming partnerships with other players within the cannabis sector to increase their combined reach. Wildflower has recently done this through a delivery fulfillment agreement with HelloMD, a leading digital healthcare platform for cannabis doctors, consumers and brands. The deal will allow Wildflower to potentially reach more customers through HelloMD’s expansive e-commerce platform.
Such moves should increase opportunities for CBD businesses to accelerate their expansion and reach a broader customer base, reversing years of prohibition. These partnerships may not only boost individual businesses but also add to the rising tide of CBD.
Cannabis Leaders Emerge
Celebrated leaders are starting to emerge at the head of the cannabis industry. Some have come from outside, their fame drawing attention to the industry. Others have come from within.
A recent list of the top 100 figures in the industry includes actor Jim Belushi, former Mexican president Vicente Fox and retired boxer Mike Tyson. The list also includes cannabis executives such as Terry Booth of Aurora and Elizabeth Hogan of GCH.
Wildflower Brands CEO William MacLean was included in the list, thanks to his hands-on approach to sales and marketing. His extensive travels to hospitals in North America have also given him insight into patient experience and the benefits that cannabis and CBD can offer. Combined with years of marketing experience, this impressive background puts MacLean in a strong position to market his brand and build teams of skilled experts for ongoing growth.
Cannabis Companies Reach New Highs
As the cannabis sector expands, many companies are going through periods of growth and rising revenues. Over the past few years, this rocketing trajectory has allowed the cannabis sector to diversify in interesting ways.
Based in Canada, Tilray Inc. (NASDAQ: TLRY) is looking to expand through acquisitions. The company recently acquired the largest hemp foods company in the world — Manitoba Harvest — to strengthen its foothold in the exploding hemp market. The company is also making other strategic growth and development moves, including moving into Europe.
Aphria (NYSE: APHA) (TSX: APHA) recently received a license amendment to expand its growing space. Headquartered in Leamington, Ontario, Aphria is working to set the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Aphria is committed to bringing breakthrough innovation to the global cannabis market and has a presence in more than 10 countries across 5 continents.
One of the large Canadian cannabis companies, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is looking to expand in the United States following the passing of the 2018 farm bill. Canopy is building a hemp-production facility in New York state and acquired hemp enterprise AgriNextUSA, moves that position the company to make the most of America’s swing towards hemp and become a leading player as the market heats up across North America. Canopy Growth boasts an extensive range of licenses and distribution deals north of the border, giving it a strong base from which to build its U.S. business.
The Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) recently closed a deal with outside company Altria, providing that company with a way into the hemp space. The C$2.4 billion strategic growth investment will provide Cronos with essential resources to expand during its critical phase of market growth in the United States.
With scientific and business innovation being led by a raft of far-sighted and innovative pioneers, the cannabis and CBD industries look set for another decade of incredible growth.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Increasing Growth, Acceptance Move CBD Market Toward Mainstream
CannabisNewsWire Editorial Coverage: The CBD market is seeing strong growth and a move towards the mainstream.
- The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
- Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
- Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.
Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Focused on the organic market, Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) has significantly increased its output to meet demand. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has earned its CEO industry-wide recognition through strong growth and a powerful place as a market leader. HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) is pushing CBD and cannabis toward the mainstream through connections with food and consumer product companies. Significant developments in science and agriculture, where Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is making great steps forward in developing low-cost high-quality hemp, is also strengthening the plant.
To view an infographic of this editorial, click here.
Growing Goodness
The CBD market has seen huge growth over the past few years, appearing out of nowhere to become an industry worth billions of dollars. This growth has been driven in large part by CBD’s potential for health and well-being, a subject that many researchers are busy exploring. Companies have leapt upon the opportunity to offer consumers the benefits associated with cannabis without some of the other issues regularly linked with the drug, including getting users high.
If the past few years have been fruitful, the future looks even brighter for CBD. Soaring sales, growing acceptance within mainstream sports, and the recognized influence of some of the major players within the broader cannabis industry all point to positive movement forward for CBD. And as companies overcome the challenges offered by distributing a previously obscure product to a broad market, the industry looks set to soar.
A Rising Global Market
The growth of the CBD market has so far come mostly out of North America, where the likes of health and wellness company Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) have marketed a wide range of CBD products. This geographical focus is thanks mostly to questions of legality, as CBD is extracted either from cannabis or from its nonhigh-inducing form hemp. Though legalization of cannabis remains variable in the United States, hemp is now legal at a national level in both the U.S. and Canada, with cannabis growth widely permitted.
As a result, the North American cannabis market, including that for CBD, has grown in spectacular fashion. The market was worth $9.2 billion in 2017 and is predicted to reach $47.3 billion by 2027. It’s this market that has proved so fruitful for the likes of Wildflower Brands.
The European CBD market has seen less expansive growth. Within the EU, the range of processed products that can be made incorporating cannabis is more limited, and there’s been less of a concerted push towards legalization for both CBD and cannabis products. Consequently, market growth there has been less impressive.
But that may be about to change, according to analysis from market intelligence firm the Brightfield Group. The company recently predicted 400% growth in the European CBD market from 2018 to 2023, a massive rise in a short five-year span. It looks as if the CBD boom may be set to go global.
Sports and CBD
Of course, the CBD market hasn’t only been shaped by years of cannabis prohibition; contributing factors also include society’s acceptance of cannabis and CBD. The rules of organizations not normally associated with cannabis can provide a hindrance to companies such as Wildflower Brands. But as the legal market develops, those institutions are shifting their attitudes as well.
The world of sports is an ideal example. During the war on drugs, many teams, leagues and professional organizations took a firm public stance against cannabis, laying down rules that prevented their players from indulging. The NFL, for example, has strict rules against cannabis consumption. Currently, however, former players are campaigning for a change to those rules, not just to allow players access to the same experiences as other people but to tackle issues specifically related to sports.
Cannabis and CBD are used in a wide range of pain treatments and products, including those such as Wildflower’s topical treatments. Given the injuries frequently incurred in professional sports, pain management is essential, and players seek access to the best range of medicines. Currently the ban on cannabis and CBD restricts players from choosing such seemingly effective options, fueling the call for change.
Changes could also have a significant impact on the sponsorship side. Currently, only one professional sports team in the United States has a cannabis-related sponsorship, despite the growing wealth and influence of the industry. As barriers come down, the time may come for CBD, much like other recreational and medical products, to gain attention in the sport and beyond through sponsorship and supporter arrangements.
The Challenge of Delivery
Of course, all this expansion comes with significant challenges. As the market grows and evolves, CBD companies must find ways to distribute products to a sector that didn’t exist a decade ago. The infrastructure most other industries take for granted is being built from scratch.
Fortunately, the companies moving into this space are willing to adapt and move quickly to support their expansion. This involves forging alliances with other players within the cannabis sector to increase their combined reach. Wildflower has recently done this through a delivery fulfillment agreement with HelloMD, a leading digital healthcare platform for cannabis doctors, consumers and brands. The deal will allow Wildflower to potentially reach more customers through HelloMD’s expansive e-commerce platform.
Such moves should increase opportunities for CBD businesses to accelerate their expansion and reach a broader customer base, reversing years of prohibition. These partnerships may not only boost individual businesses but also add to the rising tide of CBD.
Cannabis Leaders Emerge
Celebrated leaders are starting to emerge at the head of the cannabis industry. Some have come from outside, their fame drawing attention to the industry. Others have come from within.
A recent list of the top 100 figures in the industry includes actor Jim Belushi, former Mexican president Vicente Fox and retired boxer Mike Tyson. The list also includes cannabis executives such as Terry Booth of Aurora and Elizabeth Hogan of GCH.
Wildflower Brands CEO William MacLean was included in the list, thanks to his hands-on approach to sales and marketing. His extensive travels to hospitals in North America have also given him insight into patient experience and the benefits that cannabis and CBD can offer. Combined with years of marketing experience, this impressive background puts MacLean in a strong position to market his brand and build teams of skilled experts for ongoing growth.
Cannabis Companies Reach New Highs
As the cannabis sector expands, many companies are going through periods of growth and rising revenues. Over the past few years, this rocketing trajectory has allowed the cannabis sector to diversify in interesting ways.
One of those is the growing interest in organic and sustainably grown cannabis, which aligns with the existing market for organic fruit and vegetables. Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) has seen success moving into this niche and is now growing to meet the massive demand. The company is building two new facilities to expand its production base, with growing capacity set to increase from 156,000kg to 202,500kg. Green Organic Dutchman is also looking at the wider global market, with an investment in Jamaican cannabis.
One of the largest cannabis companies in Canada, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has benefited from that country’s liberal approach to the issue. Early and widespread legalization have given Canadian cannabis companies an opportunity to expand in both the recreational and the medical markets. Aurora is one of the highest trading cannabis stocks on the NYSE and is going from strength to strength. The company’s acquisition of 51% interest in a Portuguese cannabis company has positioned the Aurora for expansion in Europe as that market starts to mature.
Like many cannabis companies, HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) started out as a medical provider but has shifted to include the recreational market in its work. As the first cannabis producer to join Food & Consumer Products of Canada (FCPC), the company is offering cannabis products as part of its wider range of consumables, reducing the stigma and barriers to entry. Such bold moves have led to a 1,269% increase in gross revenue, a performance made possible by a combination of strong leadership and market growth.
Some companies are focused only on CBD, such as Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB). The company’s work in producing high-quality, low-cost hemp through proprietary genetics earned its vice president of cultivation Jared Stanley a place in the cannabis top 100. The science of cannabis cultivation is still in its infancy, but it’s moving fast, and by improving knowledge and techniques, pioneers such as Stanley are laying the groundwork for future growth.
With scientific and business innovation being led by a raft of far-sighted and innovative pioneers, the cannabis and CBD industries look set for another decade of incredible growth.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
CBD Surges into Mainstream with New Products, Celebrity Endorsements and Emerging Consensus about Benefits
CannabisNewsWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.
- Growing CBD market could eclipse broader cannabis market
- Consensus about health benefits backed by clinical work, personal endorsements lead to heightened interest
- CBD found in vast array of new products
As CBD moves into the mainstream, opportunities are likely to grow exponentially for a variety of companies, including plant-based health and wellness product developer Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile). Canadian company Tilray Inc. (NASDAQ: TLRY) is riding the wave by acquiring Manitoba Harvest, the world’s largest hemp foods company. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) recently announced it has closed a billion-dollar equity investment from an outside company. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) just received a cultivation license from Health Canada for its facility in New Brunswick. Aphria (NYSE: APHA) (TSX: APHA) also received additional licensing approval from Health Canada, permitting the company to commence production in an additional 800,000 square feet of facilities.
To view an infographic of this editorial, click here.
An Established Wellness Ingredient Goes Mainstream
The recent passage of the Hemp Farming Act in the 2018 U.S. farm bill made hemp an ordinary agricultural commodity, swinging open the door for hemp-derived CBD. The industry is seeing everyone from A-list celebs at the Oscars to noted medical professionals such as American neurosurgeon Dr. Sanjay Gupta extolling the therapeutic benefits of CBD.
Already incorporated into to a wide variety of functional foods and beverages, CBD has also started to show up in coffee and cocktails, with specialty CBD drinks joining the menus at bars and coffee shops across America. Many users swear by the efficacy of CBD to combat ailments such as anxiety, sleeplessness or physical pain.
With mounting therapeutic credence and a raft of celebrity endorsements, its little wonder that CBD has exploded into the mainstream. Product developers have been scrambling to incorporate cannabidiol into every kind of consumer product imaginable, from health and beauty items for the skin to tasty treats for the family pet. The accumulating evidence for CBD’s health benefits also owes a great deal to watershed achievements such as Epidiolex, a CBD-derived anti-seizure medication that has been through numerous clinical trials, becoming the first FDA approved cannabis-based drug utilized to treat severe forms of childhood epilepsy.
There’s an emerging consensus among consumers that CBD has broad ranging medicinal benefits with the ability to treat something as serious as epilepsy yet also safe enough to be used for daily aches and pains or address a myriad of anxieties and ailments. This awareness, combined with the rapid proliferation of CBD consumer products ranging from vape pens to functional foods, has led to a veritable grassroots market revolution.
Any lingering stigma or confusion between CBD and THC is rapidly eroding, particularly with the likes of homemaking legend Martha Stewart now providing her knowledge of consumer products to CBD developers. And household names such as Kim Kardashian, Olivia Wilde and Jennifer Aniston are also going on record as having enjoyed the health benefits associated with their personal consumption of CBD products.
Growing Consensus about Healing Power of Plants
Grabbing A-list celebrity attention, the Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) CBD+ Healing Stick was in each of the gift bags of the stars during Oscar weekend 2019. Packing 500mg of highly concentrated, full-spectrum CBD, Wildflower’s cooling and soothing stick is easy to apply for targeted pain relief and skin care, providing relief through a unique CBD blend that includes therapeutic ingredients such as arnica, wintergreen and other essential oils.
An established, respected brand, Wildflower Wellness’s overriding mission is to connect people to the healing power of plants via the company’s increasingly sophisticated line of CBD vaporizers, capsules, tinctures, soaps and topicals - formulating its extracts with essential amino acids and beneficial terpenes, the organic compounds that provide flavor and scent. A testament to the popularity of Wildflowers’ proprietary formulations can be found in a NY Magazine article “The Best CBD and Hemp Products for the Tasteful Non-Stoner” touting the company’s CBD Immunity Vaporizer, stating that, “Wildflower also made the perfect CBD starter kit…”
The company’s products are made in the United States at Wildflower’s GMP facilities, third-party lab tested and backed by a 100 percent satisfaction guarantee. Wildflower's well-formulated, convenient and consumer conscious products such as its disposable ACHES CBD+ vaporizer are increasingly enjoying widespread acceptance, in part due to education of the consumers by cannabis and wellness influencers.
Flexing its branding and marketing muscle, Wildflower Wellness partnered with Bridges General to take that company’s reimagined convenience store concept to the next level. The partnership fuses together the immense popularity of the Bridges General design-centric retail space that delivers convenience for the on-the-go urban professional with an engaging opportunity to experience and learn about the benefits of CBD. The partnership is already serving some of the most powerful and influential people in the country at its Lower Manhattan store, as well its Madison Avenue Bridges General store. Further expanding reach, Wildflower has also engaged Retail Worx to establish shop-in-shop retail availability at more than 20 locations in the heart of New York City’s booming cannabis market.
Industry Seeing Retail Renaissance in Consumer Products
Wildflower continues to expand its impressive retail reach, with the Wildflower Wellness brand already enjoying distribution in key states, such as Washington at more than 200 retailers. The company’s California-based King Extracts brand is focused on cannabis technology and delivery systems. The company’s King Extracts product, the King Recharge, is a discreet but powerful little pocket vaporizer that comes in its own sleek charging and storage case, which has room for two 500mg cartridges and a backup battery.
King Recharge offers fractionally distilled CO2 extractions in exceptionally clean and sophisticated blends that utilize proprietary terpenes in order to deliver a full, robust flavor profile. Sativa, Indica and Hybrid, as well as two limited-edition Sativa flavors (watermelon and bubble gum), are currently available. Additionally, Wildflower’s growing national distribution arm includes over 80 other wellness and healthcare practitioners, bringing the company’s total to some 300-plus stores nationwide.
The company has even branched out into physical retail itself, harnessing the power of increasing brand recognition, a firm footing in the California market and tightly knit relationships with local hospital oncology departments and community programs. Wildflower has launched its own dispensary in Los Angeles and provides on-demand, legal and licensed cannabis delivery services to adults in the L.A. area. The second quarter of 2019 saw the 10th consecutive quarter of increased revenue for Wildflower, with $1.4 million in sales underscoring a burgeoning direct-to-consumer online channel that witnessed 300 percent growth last year alone.
Many analysts are saying that the CBD rush is just getting started. One recent estimate indicates that the CBD market alone could eclipse the entire remainder of the cannabis market combined. Wildflower is making all the right moves to capture an outsized share of the CBD bonanza.
A Rising Tide Lifts All Boats
Other companies are recognizing the potential profit CBD may provide. Canadian company Tilray Inc. (NASDAQ: TLRY) just finalized its acquisition of Manitoba Harvest, a move Tilray president and CEO called a milestone for the cannabis industry. "It builds on the strategic partnerships we have formed with consumer brand industry leaders and demonstrates our track record of disrupting the global pharmaceutical, alcohol, CPG, and functional food and beverage categories,” said Brendan Kennedy. The deal gives Tilray access to a broad portfolio of food products that are distributed in 16,000 stores across the United States and Canada, as well as the opportunity to expand beyond the food category, possibly including extracts.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) just closed a C$2.4 billion investment from Altria, the American company behind brands such as Marlboro and Benson & Hedges. The move is a sign of the huge interest the CBD market is generating from companies both in and outside the industry. Cronos operates two wholly owned, Canadian-licensed producers and has multiple international production and distribution platforms and partnerships across five continents. Cronos intends to continue to expand its global footprint as it focuses on building an international iconic brand portfolio and developing disruptive intellectual property. The company is committed to building industry-leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.
Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) predicts the new facility in Fredericton, New Brunswick, will produce more than 5,000kg of cannabis annually, with first harvests expected to become available to the market within six months. In addition, the company expects to create more than 130 jobs at the plant. “New Brunswick has emerged as a leader in the legal cannabis sector, and the province is an excellent place to do business,” said co-CEO and Canopy Growth chairman Bruce Linton. “We will leverage our existing operational expertise to ensure we support the needs of our customers while making a meaningful contribution to the local economy primarily through new job creation.”
As part of its Part IV and Part V expansions, Aphria (NYSE: APHA) (TSX: APHA) is increasing production at its Aphria One location. The expansions brig industry-leading automation to the company. While critical phases such as initial cuttings, trimming and pruning mature plants will be performed by hand, the in-house designed technology will automate key steps, including transplanting cuttings, transplanting plans through harvesting, de-budding and rough trimming, drying and curing, and waste disposal.
With the 2018 Farm Bill thrusting hemp-derived CBD into the limelight, the broader industry likely stands to experience a rising tide that will lift all boats.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.come and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
CBD Going Mainstream amid Flood of New Products, Celebrity Endorsements, and Emerging Consensus about Benefits
CannabisNewsWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.
- $22 billion-plus CBD market could eclipse broader cannabis market
- Growing consensus about health benefits backed by clinical work, personal endorsements
- CBD found in everything from beverages and dog treats to pharmaceuticals and wellness products
The opening of the CBD floodgates represents a huge opportunity for plant-based wellness and health-product developers such as Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) and Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB), a lifestyle-oriented developer of cannabis and CBD consumer products. Similarly, some of the fastest-growing producers in the industry today, such as Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) and HEXO Corp. (NYSE: HEXO) (TSX: HEXO) all stand to benefit as the rising tide of the CBD market continues to see tremendous growth for a number of reasons.
To view an infographic of this editorial, click here.
An Established Wellness Ingredient Goes Mainstream
The recent passage of the Hemp Farming Act in the 2018 U.S. farm bill made hemp an ordinary agricultural commodity, swinging open the door for hemp-derived CBD. The industry is seeing everyone from A-list celebs at the Oscars to noted medical professionals such as American neurosurgeon Dr. Sanjay Gupta extolling the health benefits of CBD.
Already incorporated into to a wide variety of functional foods and beverages, CBD has also started to show up in coffee and cocktails, with CBD drinks being added to menus at bars and coffee shops across America. Many users swear by the efficacy of CBD to combat ailments such as various anxieties, sleeplessness or physical pain. Little wonder that CBD is going mainstream, and product developers have been racing to put the stuff into every kind of consumer product imaginable, from health and beauty items for the skin to tasty treats for the family pet. The accumulating evidence for CBD’s health benefits also owes a great deal to watershed achievements such as Epidiolex, a CBD-derived anti-seizure medication that has been through numerous clinical trials, becoming FDA-approved in severe forms of childhood epilepsy.
There appears to be an emerging consensus among consumers that CBD is strong enough to treat something like epilepsy but also safe enough to be used for daily aches and pains or address the myriad anxieties that plague the modern mind. This awareness, combined with the rapid proliferation of CBD consumer products ranging from vape pens to functional foods, has led to a kind of grassroots market revolution. Any stigma remaining due to laymen confusing CBD with THC is rapidly eroding, particularly with the likes of homemaking legend Martha Stewart now providing her knowledge of consumer products to CBD developers. And household names such as Kim Kardashian, Olivia Wilde and Jennifer Aniston are also going on record as having enjoyed the health benefits associated with their personal consumption of CBD products.
Growing Consensus about Healing Power of Plants
Speaking of A-list celebrities and CBD products, it was the Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) CBD+ Healing Stick that found its way into the gift bags of the stars during Oscar weekend 2019. Packing a walloping 500mg of highly concentrated, full-spectrum CBD, Wildflower’s cooling and soothing stick is easy to apply for targeted pain relief and skin care, providing relief through a unique CBD blend that includes therapeutic ingredients such as arnica, wintergreen and other essential oils.
A reputable brand whose stated mission is to connect people to the healing power of plants via the company’s increasingly sophisticated line of CBD vaporizers, capsules, tinctures, soaps and topicals, Vancouver-based Wildflower Wellness packs its extracts with essential amino acids and beneficial terpenes, the organic compounds that give plants flavor and scent.
The company’s products are made in the United States at Wildflower’s GMP facilities and are third-party lab tested; they are also backed by a 100 percent satisfaction guarantee. Such well-formulated, convenient and discrete products as Wildflower's disposable ACHES CBD+ vaporizer are increasingly enjoying widespread acceptance. This is in part due to education of the consumers by cannabis and wellness influencers.
Wildflower Wellness has even partnered with Bridges General to take that company’s reimagined convenience store concept to the next level. The partnership fuses together the popularity of the Bridges General design-centric retail space that delivers convenience for the on-the-go urban professional with an engaging opportunity to experience and learn about the benefits of CBD. The partnership is already serving some of the most innovative minds in tech at its Lower Manhattan store, as well its Madison Avenue Bridges General store. The company has also engaged Retail Worx to establish shop-in-shop retail availability at more than 20 locations in the heart of New York City’s booming cannabis market.
Industry Seeing Retail Renaissance in Consumer Products
Wildflower also has a surprisingly impressive retail reach for a company of its size, with the Wildflower Wellness brand already enjoying distribution in key states, such as Washington at more than 200 retailers. The company’s California-based King Extracts brand is focused on cannabis technology and delivery systems.
King Extracts’ flagship product, the King Recharge, is a discreet but powerful little pocket vaporizer that comes in its own sleek charging and storage case, which has room for two 500mg cartridges and a backup battery. King Recharge offers fractionally distilled CO2 extractions in exceptionally clean and sophisticated blends that utilize proprietary terpenes in order to deliver a full, robust flavor profile. Sativa, Indica and Hybrid, as well as two limited-edition Sativa flavors (watermelon and bubble gum), are currently available. Additionally, Wildflower’s growing national distribution arm includes over 80 other wellness and healthcare practitioners, bringing the company’s total to some 300-plus stores nationwide.
The company has even branched out into physical retail itself, harnessing the power of increasing brand recognition, a firm footing in the California market and tightly knit relationships with local hospital oncology departments and community programs. The company has launched its own dispensary in Los Angeles and provides on-demand, legal and licensed cannabis delivery services to adults in the L.A. area. The second quarter of 2019 saw the 10th consecutive quarter of increased revenue for Wildflower, with $1.4 million in sales underscoring a burgeoning direct-to-consumer online channel that witnessed 300 percent growth last year alone.
Many analysts are saying that the CBD rush is just getting started. One recent estimate indicates that the CBD market alone could eclipse the entire remainder of the cannabis market combined. Wildflower can apparently read the handwriting on the wall and intends to apply the $1.882 million in proceeds from the company’s recent, oversold private placement to good use.
A Rising Tide Lifts All Boats
Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB) is also enjoying the upside as CBD goes mainstream, with increasing traction for the company’s Seventh Sense CBD-infused body care collection. Similar upside is being seen across the company’s other retail arms, including curated product mix Meri+Jayne, CAMP lifestyle product kiosks, women’s wellness focused Green Lily and Nevada-based The +Source dispensaries. Its Indiana shop marks the start of a massive retail push that will see Green Growth Brands leverage newly gained access to some 108 prime retail locations at thriving malls throughout the United States. The push is backed by an $85 million private placement from late last year, which will also bolster the company’s XanthicBiopharms operation and may open the door to a variety of strategically significant new products.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), one of the biggest and fastest growing producers in the industry today, has seen a somewhat meteoric rise since opening the company’s initial facility in Alberta in 2013. Today, Aurora is engaged in an aggressive international expansion, grounded in an increasingly diverse constellation of subsidiaries and strategic partnerships. Global reach and proprietary high-yield production technologies and techniques have put Aurora on the map as a funded producer, which can deliver more than 500,000 kilograms per year.
Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD), a premier certified organic Canadian producer, is another input supplier benefitting from the increased market exposure CBD has been getting, with 2018 being a pivotal year for the company. Green Organic Dutchman executed two bought deals worth $101.2 million in gross proceeds and pulled another $77.6 million in gross proceeds via private placements. The company was also able to report a healthy $263.5 million in cash and restricted cash for 2018. The Green Organic Dutchman is in a solid position to expand existing facilities and pursue international growth into markets such as Jamaica.
HEXO Corp. (NYSE: HEXO) (TSX: HEXO) is a notable low-cost producer with more than 579,000 square feet of production capacity and a 1,000,000-square-foot facility currently under construction. The company recently moved to acquire an additional 470,000 square feet of production space via an all-share acquisition of Newstrike Brands Ltd., valued at approximately $263 million. This news comes on the heels of the company’s recent announcement that it is the first cannabis company to join the FCPC (Food & Consumer Products of Canada), arguably the biggest voice in Canadian food, beverage and consumer products. This prestigious feather in HEXO’s cap was acquired just days prior to announcing impressive results for what is the first full quarter following the legalization of adult-use cannabis in Canada.
With the 2018 Farm Bill thrusting hemp-derived CBD into the limelight, the broader industry likely stands to experience a rising tide that will lift all boats.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
Staggering Growth Predicted for CBD Industry as Impact of Farm Bill Seen
CannabisNewsWire Editorial Coverage: Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond.
- Cannabidiol (CBD), a chemical found in cannabis, has seen a huge growth in sales over the past few years.
- CBD can be derived from hemp, and the passing of a new farm bill in the States makes this form of cultivation legal at a federal level.
- This forms part of wider growth in the cannabis market, as companies expand their operations in North America and even beyond.
Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year. Tilray Inc. (NASDAQ: TLRY) is expanding with its acquisition of hemp foods company Manitoba Harvest. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) announced revenue for its fiscal third quarter rose more than 280 percent compared to a year ago. In December, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced that tobacco company Altria would be taking a $1.8 billion stake in the company. And Aphria (NYSE: APHA) (TSX: APHA) has just completed expansion projects that allows it to substantially increase its output.
To view an infographic of this editorial, click here.
CBD Drives Growth for Hemp
Hemp, a plant that has long been out of the public eye, is returning to the spotlight in a big way. A nonintoxicating form of cannabis, hemp was primarily used for centuries as a natural source of fibers, which were used in cloth, rope and even building materials. Many ships in the great age of sailing relied on hemp for their riggings.
But in the sweeping anti-drug crusades of the 20th century, hemp became caught up in attacks on cannabis. Campaigners who were determined to save consumers from their own pleasures had cannabis outlawed at a time when there was little effective way of distinguishing between hemp and other forms of cannabis. No longer needed for cloth and rigging, hemp was made illegal.
Now all that has changed — nowhere more dramatically than in the United States of America.
The Farm Bill
Hemp is making a comeback thanks to the growing popularity of cannabidiol (CBD), an active ingredient found in many forms of cannabis. It’s an ingredient that companies such as Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN), a creator of plant-based health and wellness products, have been making extensive use of in recent years. Combined with other naturally occurring plant compounds, full-spectrum CBD is used in a range of Wildflower products, including capsules, topicals, soaps, tinctures and vaporizers.
Until recently, the production of CBD in the United States faced serious restrictions and uncertainties. Many states had legalized the production of cannabis in some form, either for medical or for recreational use. In addition, there were licensed trials of the cultivation of hemp, which can be rich in CBD. But all of these plants were illegal at a federal level, meaning that even with state-level approval, cultivators faced financial limitations and the threat of government action.
All that changed in December with the passage of the 2018 Farm Bill. One of a regular series of bills governing the U.S. agricultural sector, this bill removes hemp from the list of controlled substances, making it unambiguously legal for farmers to grow hemp. This changes the landscape for CBD products in the States. Companies such as Wildflower, which has already got its products into many outlets in the health and wellness sector, will be able to expand their reach even further.
States have the right to set their own rules around restricted substances, and some states have taken an unsympathetic attitude to CBD. The Farm Bill doesn’t force states to change this attitude, but there are already signs that public opinion on all levels are changing. The regulations in many states assume adherence to the federal guidelines, and some states, such as Alabama, have already softened their stance since the Farm Bill became law.
Under the Farm Bill, hemp production will be tightly regulated. Most states already have existing regulations in place, and the U.S. Department of Agriculture will be developing its own regulations as well. But for an established company such as Wildflower, which already works in California, Washington and New York, this shouldn’t be a problem.
Cannabis companies are accustomed to working in a tightly controlled environment and meeting the legal standards set by state legislators, as well as the product standards required by retail outlets. In that context, working within new federal regulations shouldn’t present a significant challenge, while the existence of consistent national standards will create opportunities for growth.
CBD Demand Grows
The Farm Bill has been driven in large part by the growing demand for CBD. An obscure and seldom discussed chemical a decade ago, CBD has emerged as an important consumer product. The gradual legalization of cannabis and research into its medical effects drew attention to the fact that those benefits were not all related to THC, the psychoactive chemical that gets cannabis users high. Identified as a chemical with great potential for health and wellness, CBD has started to be marketed in its own right and is used in products such as the Wildflower Wellness line.
Public interest in CBD has grown seemingly from nowhere. Tapping into interest in both cannabis and natural remedies, and offering treatments that may succeed where others have failed, CBD sales have soared. Hemp-derived CBD alone was a $390 million market in 2018 and is expected to reach $1.3 billion by 2022. And that doesn’t even include all the CBD products derived from other forms of cannabis.
The results for producers have been staggering. Wildflower saw its online sales grow by more than 300 percent in just nine months in 2018. In response, the company opened its first New York retail store, a sure sign of a product’s popularity in an age when so many companies are shedding their brick-and-mortar presence.
Looked at globally, CBD is in even better health. The Brightfield Group has estimated that CBD’s value will reach $5.7 billion this year and $22 billion by 2022. While research on the topic is still in its infancy, there is growing evidence that CBD could be used to treat a number of ailments, including certain extreme forms of childhood epilepsy. Even the United Kingdom, a country whose government remains staunchly opposed to the legalization of cannabis, has allowed the use of a CBD drug for this purpose.
Companies producing and selling CBD products are springing up across North America, Europe and beyond. Demand is growing, especially among millennials. That’s bolstering the impressive sales of companies such as Wildflower and putting pressure on politicians to further liberalize the laws around hemp.
Making the Most of a New Market
A lot of companies are now making the most of the growing popularity of cannabis, CBD and hemp. With its acquisition of Manitoba Forest, Tilray, Inc. (NASDAQ: TLRY) is tapping into an extensive U.S. distribution network and an upcoming line of CBD products. Manitoba Harvest sells hemp-based granola, protein powder, milk and other food products at more than 13,000 points of sale across the United States.
Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) impressive increase in sales was boosted by the company’s first sales of legal recreational marijuana in Canada, which accounted for more than 70 percent of gross revenue. Chairman and co-CEO Bruce Linton attributed the lift to the company's decision to make early, "meaningful" investments that helped it corner a big part of the Canadian market when the law took effect. Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and softgel capsule forms.
Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON), which became the first marijuana stock to uplist from the over-the-counter exchange to a major U.S. exchange, appears poised to benefit from its move with Altria. Altria now has a 45 percent stake in Cronos, with the ability to exercise warrants it also received to boost its stake up to 55 percent. Should those warrants be exercised, Cronos would receive an additional $1.05 billion. Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across five continents. Cronos Group operates two wholly-owned Canadian licensed producers: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia.
Aphria (NYSE: APHA) (TSX: APHA) recently announced that Health Canada has granted the company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the company’s completed Part IV and Part V expansions. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible.
Savvy companies, such as Wildflower Brands Inc., are making the most of legal moves in the United States and Canada that have created momentum and exciting opportunities for growth.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
NetworkNewsWire
7年前
CBD Industry Soars in Wake of Farm Bill; Massive Growth Projected to Continue
CannabisNewsWire Editorial Coverage: Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond.
- Cannabidiol (CBD), a chemical found in cannabis, has seen a huge growth in sales over the past few years.
- CBD can be derived from hemp, and the passing of a new farm bill in the States makes this form of cultivation legal at a federal level.
- This forms part of wider growth in the cannabis market, as companies expand their operations in North America and even beyond.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year. Some companies are specializing in particular niches, such as The Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) with its focus on sustainable organic plants. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) is making moves into Europe, with cannabis oil sales in Germany and investment in a Portuguese grower. Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB) is launching new products and opening its own shops across the United States. And HEXO Corp. (NYSE: HEXO) (TSX: HEXO), which recently expanded from medical cannabis into the recreational space, has seen gross revenue increase more than 1,000 percent as part of this rising tide.
To view an infographic of this editorial, click here.
CBD Drives Growth for Hemp
Hemp, a plant that has long been out of the public eye, is returning to the spotlight in a big way. A non-intoxicating form of cannabis, hemp was primarily used for centuries as a natural source of fibers, which were used in cloth, rope and even building materials. Many ships in the great age of sailing relied on hemp for their riggings.
But in the sweeping anti-drug crusades of the 20th century, hemp became caught up in attacks on cannabis. Campaigners who were determined to save consumers from their own pleasures had cannabis outlawed at a time when there was little effective way of distinguishing between hemp and other forms of cannabis. No longer needed for cloth and rigging, hemp was made illegal.
Now all that has changed — nowhere more dramatically than in the United States of America.
The Farm Bill
Hemp is making a comeback thanks to the growing popularity of cannabidiol (CBD), an active ingredient found in many forms of cannabis. It’s an ingredient that companies such as Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a creator of plant-based health and wellness products, have been making extensive use of in recent years. Combined with other naturally occurring plant compounds, full-spectrum CBD is used in a range of Wildflower products, including capsules, topicals, soaps, tinctures and vaporizers.
Until recently, the production of CBD in the United States faced serious restrictions and uncertainties. Many states had legalized the production of cannabis in some form, either for medical or for recreational use. In addition, there were licensed trials of the cultivation of hemp, which can be rich in CBD. But all of these plants were illegal at a federal level, meaning that even with state-level approval, cultivators faced financial limitations and the threat of government action.
All that changed in December with the passage of the 2018 Farm Bill. One of a regular series of bills governing the U.S. agricultural sector, this bill removes hemp from the list of controlled substances, making it unambiguously legal for farmers to grow hemp. This changes the landscape for CBD products in the States. Companies such as Wildflower, which has already got its products into many outlets in the health and wellness sector, will be able to expand their reach even further.
States have the right to set their own rules around restricted substances, and some states have taken an unsympathetic attitude to CBD. The Farm Bill doesn’t force states to change this attitude, but there are already signs that public opinion on all levels are changing. The regulations in many states assume adherence to the federal guidelines, and some states, such as Alabama, have already softened their stance since the Farm Bill became law.
Under the Farm Bill, hemp production will be tightly regulated. Most states already have existing regulations in place, and the U.S. Department of Agriculture will be developing its own regulations as well. But for an established company such as Wildflower, which already works in California, Washington and New York, this shouldn’t be a problem. Cannabis companies are accustomed to working in a tightly controlled environment and meeting the legal standards set by state legislators, as well as the product standards required by retail outlets. In that context, working within new federal regulations shouldn’t present a significant challenge, while the existence of consistent national standards will create opportunities for growth.
CBD Demand Grows
The Farm Bill has been driven in large part by the growing demand for CBD. An obscure and seldom discussed chemical a decade ago, CBD has emerged as an important consumer product. The gradual legalization of cannabis and research into its medical effects drew attention to the fact that those benefits were not all related to THC, the psychoactive chemical that gets cannabis users high. Identified as a chemical with great potential for health and wellness, CBD has started to be marketed in its own right and is used in products such as the Wildflower Wellness line.
Public interest in CBD has grown seemingly from nowhere. Tapping into interest in both cannabis and natural remedies, and offering treatments that may succeed where others have failed, CBD sales have soared. Hemp-derived CBD alone was a $390 million market in 2018 and is expected to reach $1.3 billion by 2022. And that doesn’t even include all the CBD products derived from other forms of cannabis.
The results for producers have been staggering. Wildflower saw its online sales grow by more than 300 percent in just nine months in 2018. In response, the company opened its first New York retail store, a sure sign of a product’s popularity in an age when so many companies are shedding their brick-and-mortar presence.
Looked at globally, CBD is in even better health. The Brightfield Group has estimated that CBD’s value will reach $5.7 billion this year and $22 billion by 2022. While research on the topic is still in its infancy, there is growing evidence that CBD could be used to treat a number of ailments, including certain extreme forms of childhood epilepsy. Even the United Kingdom, a country whose government remains staunchly opposed to the legalization of cannabis, has allowed the use of a CBD drug for this purpose.
Companies producing and selling CBD products are springing up across North America, Europe and beyond. Demand is growing, especially among millennials. That’s bolstering the impressive sales of companies such as Wildflower and putting pressure on politicians to further liberalize the laws around hemp.
Making the Most of a New Market
A lot of companies are now making the most of the growing popularity of cannabis, CBD and hemp.
Given the crossover between liberal attitudes on drugs and an interest in protecting the environment, it’s hardly surprising that specialist companies have arisen that grow organic cannabis. One of these is The Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD), which announced last year that it had signed a definitive agreement to acquire 100 percent of the issued and outstanding shares of privately held HemPoland in an immediate accretive cash-and-share transaction. The move gives Green Organic Dutchman access to HemPoland’s vast distribution network, premium Cannabigold brand, and state-of-the-art hemp oil extraction technologies, as well as providing a strategic pathway into the European market for TGOD’s medical and recreational products and licensing deals.
Canada is at the forefront of cannabis legalization, as one of the early adopters of medical cannabis and the first G8 country to legalize its recreational use. As a result, the country has developed several large cannabis companies, including Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB). Aurora has an eye on the global market for cannabis and CBD, recently agreeing to acquire a 51 percent interest in a Portuguese cannabis company, as well starting sales of cannabis oil in German pharmacies.
Like Green Organic Dutchman, Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB) is leaning into the hippy image of cannabis through a brand that places an emphasis on health, wellness and happiness. The company is doing well with the continuing CBD craze and has recently announced the opening of CBD shops in malls in Indiana and Tennessee. The company has also formed an agreement with another company to work on CBD-infused personal care products, as CBD product ranges diversify.
A leading cannabis producer, HEXO Corp. (NYSE: HEXO) (TSX: HEXO) has expanded its interests to include the recreational as well as the medical market. Focusing on cannabis’s place in the wider market, HEXO was the first cannabis producer to join Food & Consumer Products of Canada, a group representing the Canadian food, beverage and consumer products industry. This comes as the company announced a 1,269 percent increase in gross revenue compared with the same quarter a year before, growth exceeding even the impressive performance of the wider cannabis market.
The changing legal status of CBD and the popularity of its products is just one part of a wider picture of cannabis growth, a picture that appears to be bright and promising for companies establishing a stronghold in the industry.
For more information on Wildflower Brands, visit Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
JohnCM
6年前
JackAskSlap
6年前
PotterBanker
8年前
Ramp Worm
8年前
メールアドレスで登録
